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ABSTRACT 
 
 
 
 
SPEECH OUTCOMES AND HEARING PRESERVATION IN ADULTS WITH HYBRID 
COCHLEAR IMPLANTS: A SYSTEMATIC REVIEW 
 
by 
 
VICTORIA DILLON 
 
 
 
 
 
Advisor: Dr. Barbara Weinstein, Ph.D. 
 
Objective: The goal of this review is to systematically review literature in order to investigate 
the speech recognition and subjective performance outcomes, as well as determine the degree of 
hearing preservation, in adult hybrid cochlear implant patients through the utilization of electric 
acoustic stimulation (EAS).  
Methods: A comprehensive search, utilizing various peer-reviewed databases, was conducted 
via the City University of New York’s (CUNY) Graduate Center Library to identify the relevant 
studies published. Inclusion criteria was studies that involved adult hybrid cochlear implant users 
which reported speech outcomes and hearing preservation, with performance outcomes obtained 
at least 12 months’ post-implantation. Studies published before 2013 were not included in this 
study in order to represent current literature in the field.   
Results: Ten studies met the inclusion and exclusion criteria for this systematic review. These 
studies included various materials to assess both speech recognition performance and subjective 
outcomes. All studies also reported on the degree of hearing preservation maintained post- 
implantation. Results revealed that, overall, subjects experienced a significant improvement in 
 	 v 
speech recognition scores in quiet and in noise. The benefit of utilizing acoustic stimulation, in 
addition to traditional electric stimulation through the cochlear implant, was also of note. 
Subjects had an overall positive improvement in subjective outcomes following hybrid cochlear 
implantation. Varying degrees of hearing were preserved after surgery, with the overwhelming 
majority maintaining “functional” hearing for EAS.   
Discussion: Significant improvements were found pre-to post-operatively in speech recognition 
outcomes and in subjective report. From this it can be concluded that these individuals, who 
would not have been traditional cochlear implant candidates, experienced significant positive 
changes from hybrid cochlear implantation. Additionally, high degrees of hearing preservation 
were maintained following surgery, further supporting the notion that cochlear implant 
candidacy criteria should be expanded to include this population. Future research may focus on 
the discontinued use of EAS, audiologist referral of this population, and the quantifying of 
benefit of the acoustic component in the hybrid cochlear implant system.    
Conclusion: This systematic review assessed the literature regarding speech outcomes, 
subjective outcomes, and hearing preservation of hybrid cochlear implant users. The positive 
findings concluded in this review many serve as justification and evidentiary support of the 
expansion of cochlear implant criteria to include this underserved population. 
Key words: “hybrid cochlear implant”, “electric acoustic stimulation”, “speech outcomes”, 
“speech recognition”, “subjective outcomes”, “quality of life outcomes”, “hearing preservation”, 
“hearing preservation surgery”.  
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 	 1 
Introduction 
 
Hybrid cochlear implantation, or Electric Acoustic Stimulation (EAS), has become an 
increasingly popular topic with the goal of expanding cochlear implantation candidacy and 
criteria. The notion of a hybrid cochlear implant came to fruition in 1995 when a senior author at 
Cochlear Americas was tasked with the concept of creating an implant electrode that could 
preserve low frequency hearing in the cochlea (Gantz et al., 2016). Traditionally, cochlear 
implants in post-lingually deafened adults have been recommended to those individuals for 
which traditional amplification is inadequate for hearing restoration. When the damage to the 
hair cells of the cochlea is so extensive they cannot be adequately stimulated acoustically, a 
cochlear implant will provide direct electric stimulation to the auditory nerve through implanted 
electrodes. This new electrical signal, rather than acoustic signal, is sent to the brain and 
interpreted as sound. The introduction of multichannel implants have worked to improve this 
encoding of speech and environmental signals into meaningful sound (Speech Processing in the 
Auditory System, 2004). Until recent years, the idea of preserving residual hearing in the cochlea 
was not a possibility, due to the acoustic trauma and damage the cochlea may experience during 
implantation surgery. However, this idea has become feasible with improved surgical techniques, 
drug delivery systems, and changes to electrode array lengths and dimensions (Gifford et al., 
2013). Most frequently, if a post-lingually deafened individual has functional hearing, it’s likely 
in the apical region of the cochlea, which tonotopically encodes low frequency acoustic signals. 
This is likely because the high frequency base of the cochlea tends to sustain the greatest damage 
first. It has been said that the hearing in this region is critical in understanding speech in noise, 
sound localization, and music appreciation. Traditional cochlear implantation speech processing 
is usually not able to preserve these finer spectral cues (Gantz et al., 2016). Hearing preservation 
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has now been made feasible and demonstrated with shorter electrodes with shorter insertion 
depth, therefore avoiding contact with apical hair cells, and with long electrodes with deep 
insertion depths, through improved surgical techniques which minimize damage to the inner ear. 
As a result of this, electrical stimulation in the basal end of the cochlea can be combined with 
traditional acoustic amplification to the preserved low frequencies in the apical end (Woodson et 
al., 2009).  
Currently, according to the Food and Drug Administration (FDA) 2000, traditional 
cochlear implantation candidacy for adults 18 years and older specifies the individual meet the 
following criteria: Moderate to severe low frequency hearing loss and profound high frequency 
hearing loss;  £50% aided sentence recognition in the ear to be implanted and £60% in the 
contralateral ear or best aided condition. Candidacy criteria is also influenced by implant 
manufacturer and insurance payer (Gifford, 2013)  Off-label usage of a cochlear implant is the 
current practice which allows deviations from the limiting criteria candidacy previously stated. 
While implant manufacturers are not allowed to promote such usage of their devices, clinicians 
are granted the professional courtesy to make such clinical determinations (Gifford, 2013). The 
FDA has released an informational sheet specifically to help clinicians navigate this 
determination, entitled, “Off-Label and Investigational Use of Marketed Drugs, Biologics, and 
Medical Devices” (FDA, 2018). The ability to make this determination comes with the 
responsibility to adhere to several conditions, including; “be well informed about the product”, 
“base its use on firm scientific rationale and on sound medical evidence”, and “maintain records 
of the product’s use and effects” (FDA, 2018)(Gifford, 2013). The ability to stretch these 
candidacy criteria will be most beneficial for those patients with atypical hearing losses, such as 
single sided deafness, patients with poor word recognition, and those with aidable low frequency 
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hearing who could benefit from electrical stimulation of the middle to high frequencies. This 
pattern of progressive down-sloping high frequency hearing loss is seen in individuals with 
familial hearing loss, ototoxicity, presbycusis, or noise-induced hearing loss (Woodson et al., 
2009). These “atypical” candidates are not considered in the current guidelines for cochlear 
implantation, however, this practice of off-label usage of medical devices has become an 
“acceptable and necessary corollary of the FDA’s mission” in order to provide adequate 
standards of care according to the U.S. supreme court (Gifford, 2013). However, there are non-
audiological considerations to account for when making such recommendations. These 
considerations include whether the patient is highly motivated, whether they have realistic 
expectations in outcomes, whether they are willing to participate in extensive follow-up, and 
whether there are other medical concerns or contraindications to surgery. Subject to these 
factors, surgeon support, and insurance approval, qualified patients now have a way to get the 
amplification and technology needed to adequately treat their hearing loss beyond what is 
possible with traditional amplification.  
The added benefits of electric and acoustic stimulation in cochlear implantation have 
been well documented. Much of these advantages are due to the current limitations of purely 
electric stimulation as they relate to low frequency acoustic cues. These limitations take form in 
the realm of music appreciation, processing in noise, and localization in space. The availability 
of low frequency pitch information in hybrid CI users has been shown to aid music perception 
abilities in terms of melody recognition and certain instrument recognition tasks. This is likely 
due to the fact that the low frequency pitch information, which is critical for these tasks, is not 
preserved in signal processing through conventional cochlear implantation, inhibiting such 
abilities (Woodson et al., 2009). Much of pitch perception is affected by the tonotopic mismatch 
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between the standard tonotopic organization and the cochlear place of electric stimulation on the 
processor map. This may lead to the detriment of music appreciation, however, it should be 
noted that studies have shown patients can overcome this change in pitch perception with 
adaptation to the device over time (Woodson et al., 2009). Other studies have revealed similar 
findings related to hybrid cochlear implant users and their music and pitch perception abilities. 
Hybrid users have also reported better sound quality, improved abilities in pitch ranking tasks, 
and improved recognition of real-world songs (Looi et al., 2012). The incorporation of low 
frequency information through acoustic stimulation is thought to enable some of the low 
frequency fine structure cues to be preserved in the signal. This increases the potential that the 
listener can extract fundamental frequency information from the signal (Kong et al., 2005). It’s 
been hypothesized that the temporal fine structure information, or the fine changes in the 
amplitude and frequency of sound over time, may be mostly lost in cochlear implant speech 
processing strategies. Researchers have proposed that listeners “might use the correlation 
between the salient pitch in low-frequency acoustic hearing and the weak pitch in the envelope to 
enhance segregation between the signal and noise” (Kong et al., 2005). Based on these studies, 
researchers have concluded that fine structure low frequency information appears to be more 
important for music perception and appreciation. Currently, the limitations of speech processing 
strategies in traditional cochlear implants and the large tonotopic mismatch in the cochlea 
affecting low frequency information seems to be evidence supporting the use of electric acoustic 
stimulation, whenever possible, for improved music perception (Looi et al., 2012). Similar 
conclusions have been suggested for the use of preserved low frequency hearing in 
understanding speech in noise. It has been hypothesized that preservation of interaural timing 
difference (ITD) cues could be responsible for improved signal to noise ratios in hybrid users 
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(Gifford et al., 2013). Interaural timing differences refers to the acoustic cue that comes from 
difference in arrival time of the signal to each ear and are most useful for low frequency sounds. 
These timing differences are thought to be somewhat lost with cochlear implantation without 
hearing preservation. A number of studies have documented the improved localization abilities 
and improved speech understanding in noise with access to low frequency acoustic hearing. It 
appears that ITD cues are part of the underlying mechanism for these abilities in this population 
of hybrid CI users (Gifford et al., 2014). Another explanation for this improved ability may be 
the use of Interaural Level Differences (ILD), the acoustic cue that comes from difference in 
sound level or loudness reaching each ear. There may also be additional support for difficult 
listening environments through a more minor use of the head and torso shadow effect. Though 
traditionally thought to be of the greatest use for high frequency information, more recently, 
research related to head related transfer functions suggest that low frequency sounds may be able 
to take advantage of this cue as well (Gifford et al., 2013). Users of EAS have the added benefit 
of taking advantage of both inter-aural timing differences and inter-aural level differences for 
improved localization abilities and separation of the target signal from noise (Gifford et al., 
2013). 
The hybrid cochlear implant has only become a possibility in recent years due to 
improved surgical techniques and an emphasis on hearing preservation within the cochlea.  In the 
first attempts to employ electric and acoustic hearing systems, CI manufacturers and surgeons 
worked with a “short” electrode array, or an electrode array that was intended not to affect or 
cover the apical end of the cochlea with low frequency hearing. With more shallow insertion into 
the cochlea and “soft surgery” techniques, surgeons attempted to preserve the delicate structures 
within the apical end of the cochlea (Woodson et al., 2009). Over time, this practice of hearing 
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preservation during cochlear implant surgery has been practiced and refined. Short electrode 
arrays are still used today at the discretion of the surgeon. More recently surgeons have moved 
towards the use of full length electrodes with surgical techniques that hope to create less acoustic 
trauma upon insertion, therefore leaving the structures intact and usable. This approach allows 
for the electrical stimulation of this region of the cochlea in the future, should the hearing decline 
and become unaidable acoustically. Some of these “softer” techniques include minimizing the 
cochlear exposure to blood and bone dust, performing a more minimally invasive cochleostomy, 
and careful insertion of the electrode array to avoid damage to the basilar membrane (Woodson 
et al., 2009). Further research into surgical placement of electrodes for better hearing 
preservation has led to the development of different electrode arrays for lateral wall and 
perimodiolar placement. Lateral wall placement refers to the surgical technique of inserting the 
electrode array along the outer or lateral wall of the cochlea, farthest from the modiolus. A 
perimodiolar electrode is designed to be inserted close to the medial margin of scala tympani 
closest to the modiolus (Group Product Manager, Surgical & Implants, Cochlear Limited, New 
South Wales, Australia & Risi, 2019). Researchers believe that lateral wall electrodes may be 
better for hearing preservation as they were designed to be flexible and cause minimal damage to 
the most important delicate structures upon insertion. With surgical techniques and electrode 
arrays only improving, hearing preservation has become possible. With greater hearing 
preservation comes greater ability to utilize the low frequency hearing for hybrid cochlear 
implant users.  
The goal of this systematic review is to review the literature in order to determine the 
speech recognition and subjective performance outcomes, as well as hearing preservation 
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outcomes, of adult hybrid cochlear implant patients or those that use EAS. The following 
research questions will be addressed: 
1. Does electric acoustic stimulation (EAS) through the use of hybrid cochlear implants improve 
speech recognition outcomes in adults? If so, to what degree? 
2. What were the subjective improvements experienced by the EAS subjects on qualitative 
outcome measures? 
3. What proportion of hybrid cochlear implantees maintained low frequency residual hearing 
following cochlear implant surgery? If so, to what degree was low frequency hearing preserved? 
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Methods 
 
A comprehensive review was performed investigating speech outcomes and hearing 
preservation of adults with hybrid cochlear implants or electric acoustic stimulation systems. A 
literature search was conducted via the Mina Rees Library databases of the Graduate Center of 
The City University of New York (CUNY) to identify relevant studies published. Databases 
included PubMed, Medline Complete, Google Scholar, ProQuest, EBSCO, PsycINFO, and Web 
of Science. Various combinations of the following key terms were used to locate the pertinent 
literature: “cochlear implant”, “hybrid cochlear implant”, “hybrid”, “adult”, “electric acoustic 
stimulation”, “EAS”, “speech outcomes”, “speech in noise”, “speech recognition”, “hearing 
preservation”, “hearing preservation surgery”, “severe to profound hearing loss”, “quality of life 
outcomes”, “subjective outcomes”, “low frequency pure tone thresholds”, “candidacy”.  
 Inclusion and exclusion criteria in this review were put in place to capture the relevant 
subject pool, while allowing for a substantial range of patients. Inclusion criteria included the 
following: Adult subjects 18 years and older, users of one of the three major cochlear implant 
manufacturers (Advanced Bionics, Cochlear Americas, Med-El), auditory performance/ speech 
outcomes obtained at least one-year post-cochlear implantation, adult-onset hearing loss, and 
reported hearing preservation outcomes. Exclusion criteria included the following: Studies 
published prior to 2013 to represent current literature in this field, pediatric subjects or patients 
17 years of age or younger, unspecified follow-up period, unspecified device types, excessively 
small sample size (n < 6 subjects). Additional search-based exclusion criteria included non-
English articles (not translated), articles that were not available as full-length, unpublished 
articles, or non-peer reviewed articles. It should be noted that in some studies, data was taken 
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from multi-center trials and therefore there is the potential for subject cross-over amongst the 
studies included in this review.  
 The inclusion and exclusion of the published studies discussed in this systematic review 
was guided by and outlined by the PRISMA (Preferred Reported Items for Systematic Reviews 
and Meta-Analyses) checklist and flow diagram (The PRISMA group, 2009). Application of 
these criteria resulted in 10 articles being chosen for this review. 
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Results 
Figure 1 shows a PRISMA flowchart of the literature search and retrieval process for this 
systematic review. The initial database search yielded a total of 171 studies. Perusal of abstracts 
of retrieved articles as well as elimination of articles outside of specified range of publication 
year, resulted in the elimination of 136 articles.
  
Figure 1. PRISMA flowchart of the literature search, retrieval process and selection of studies 
for this systematic review (The PRISMA group, 2009). 
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This culminated in 35 full-text articles which were assessed for eligibility in this review. After a 
thorough examination of the articles, 25 were eliminated for the following reasons: article did 
not include speech outcomes/measures, article did not specify a follow-up period and/or follow-
up time was <12 months, articles included pediatric or child subjects, article had a sample size 
<6 subjects, article was a review article or was not peer-reviewed. Application of this criteria 
resulted in 10 eligible articles to be included in this review.  
 
Study Characteristics 
Table 1 displays a number of characteristics regarding the studies included in this review. 
It includes the study type or design, the speech measures and materials used, the subjective 
measures and materials used, the timeline of follow-up testing, the condition(s) in which subjects 
were tested, and the studies defined degrees of hearing preservation.  
 Inspection of Table 1 reveals that 80% (8 of 10) of studies were prospective in nature, 
while two studies, Roland, J. T. et al, 2018 and Santa Maria et al., 2013, were retrospective. Of 
the 10 studies included, 5 studies were from, or were a part of, a multicenter trial or study inside 
and outside the United States. The speech materials used to determine speech recognition 
outcomes varied, with some common measures throughout. The most common measure used to 
assess outcomes pre- and post-operatively was consonant-nucleus-consonant (CNC) words. 50% 
(5 of 10) studies included CNC words as one of their speech measures. Several of the studies 
also included some kind of speech in noise measure. These other materials included CUNY 
sentences in noise, Bamford-Kowal-Bench Speech-in-Noise Test (BKB-SIN), AzBio sentences 
in noise, and a number of other unspecified speech in noise tests in the language of the country 
of origin. As a secondary measure, subjective tests and questionnaires, based on patient report, 
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were also extracted from the data. The most common subjective outcome measure used was the 
Speech and Spatial Qualities scale (SSQ). 4 of the 7 studies which identified a subjective 
measure used the SSQ to assess subject’s subjective improvements following cochlear 
implantation in a number of contexts. Other subjective measures included the Abbreviated 
Profile for Hearing Aid Benefit (APHAB), Glasgow Benefit Inventory (GBI), Glasgow Hearing 
Aid Benefit (GHABP), and a Likert scale to measure quality of experience. The timeline of 
subject’s follow-up was also reported to ensure there was a minimum of 12 months of cochlear 
implant usage when final measurements were recorded. All studies did various forms of testing 
pre-operatively. Post-operatively, the follow-up timeline ranged from at the initial activation, or 
approximately 1-month post-operatively, to over 5 years post-operatively. The most common 
follow-up timeline was 1 month, 3 months, 6 months, and 12 months post-operatively. 4 studies 
(Carvalho et al., 2013; Härkönen et al., 2017; Roland et al., 2018; Santa Maria et al., 2013) 
recorded measurement points well beyond 12 months post-operatively. Due to the great variety 
in testing conditions, as well as the differences of in-study comparisons, the amplification 
conditions in which subjects were tested were also reported. 6 of the 10 studies required subjects 
to be tested in a number of different amplification configurations. The most common 
comparisons were combinations of the hybrid cochlear implant, the hybrid cochlear implant with 
a contralateral hearing aid, the cochlear implant with electric stimulation only (no acoustic 
component), or bilateral hearing aids (acoustic hearing only). The allowed researchers to make 
in-study comparisons about the use of EAS and its potential benefits. The final study 
characteristic reported was the studies defined degrees of hearing preservation. Each study 
defined degrees of hearing preservations differently to reflect what they considered “functional” 
verses “non-functional” hearing preservation. All studies also reported how many subjects 
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experienced a total loss of hearing following surgery. Some studies chose to report when the 
subject maintained some degree of preserved hearing, but that preserved hearing was non-
functional for the purpose of electric acoustic stimulation through the hybrid cochlear implant. 
Other studies chose to report this as hearing that was beyond the limits of the audiometer used to 
obtain thresholds. Degrees of hearing preservation were most often based on changes in the low 
frequency pure tone average. Degrees of preserved hearing in the high frequencies were not 
reported due to their inconsequentiality to acoustic stimulation through the hybrid cochlear 
implant. 
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Table 1. Study Characteristics 
 
Study Study Type Speech Outcomes 
Materials/ Measures 
Subjective 
Materials/ 
Measures 
Timeline of 
Follow-up 
Testing 
Subject Testing 
Condition 
Degrees of Hearing 
Preservation 
Specified 
Adunka, O. F., et al. 
(2013). Hearing 
preservation and speech 
perception outcomes 
with electric-acoustic 
stimulation after 12 
months of listening 
experience: Hearing 
Preservation and Speech 
Perception Outcomes 
with EAS. (Adunka et 
al., 2013) 
Single Center 
data from a 
prospective, 
multicenter 
clinical trial 
CNC words in quiet; 
CUNY sentences in noise 
(+10dB/+5dB SNR) 
--- Pre-operatively; 
3 months’ post-
op;  
6 months, post-
op;  
12 months’ 
post-op 
(1) Hearing aid alone  
(2) CI alone  
(3) EAS 
No hearing 
preservation;  
Partial hearing 
preservation [mean 
threshold changes 
reported by 
frequency] 
Carvalho, G. M. et al. 
(2013). Hearing 
Preservation after 
Cochlear Implantation: 
UNICAMP Outcomes. 
(Carvalho et al., 2013) 
Prospective 
Cohort study  
Speech perception test 
[based on test developed 
by Bevilacqua et al. from 
several English language 
tests] 
 
Quality of 
experience 
rating using 
Likert scale 
Pre-operatively; 
at activation; 
195-218 post- 
activation (2nd 
post-op);  
174-251 days 
after 2nd post-op 
Best-aided condition  
(1) EAS if possible 
(2) CI-Only 
Total hearing 
preservation: 
postoperative unaided 
hearing loss of 0–
10 dB; 
Partial hearing 
preservation: 
postoperative unaided 
hearing loss of >10 dB 
but ≤80 dB hearing or 
better in at least one 
frequency between 
250 and 1000 Hz; 
Hearing preservation 
failure: unaided 
postoperative 
thresholds are >80 dB 
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Gantz, B. J., et al. 
(2016). Multicenter 
clinical trial of the 
Nucleus Hybrid S8 
cochlear implant: Final 
outcomes: S8 Hybrid 
Cochlear Implants. 
(Gantz et al., 2016) 
Prospective, 
multicenter, 
longitudinal, 
single-subject 
design. 
CNC words in quiet; BKB 
SIN 
Abbreviated 
Profile for 
Hearing Aid 
Benefit 
(APHAB) 
Pre-operatively; 
3 months’ post-
op;  
6 months’ post-
op;  
12 months’ 
post-op 
 
(1) Acoustic hearing 
implant ear  
(2) Acoustic hearing 
bilaterally  
(3) Hybrid CI + 
contra HA (combined 
mode)  
(4) Hybrid CI only 
(hybrid mode)  
(5) CI only (Electric 
only)  
(6) CI (electric only) 
+ contra HA 
(bimodal)  
(7) Ipsilateral acoustic 
only 
Functional hearing 
preservation (<85-90 
dBHL PTA of 125 to 
1kHz [LFPTA]); 
Non-functional 
hearing preservation 
(>90 dB LFPTA); 
Total loss of hearing 
(>130dBHL) 
Härkönen, K., et al. 
(2017). Hybrid cochlear 
implantation: quality of 
life, quality of hearing, 
and working 
performance compared 
to patients with 
conventional unilateral 
or bilateral cochlear 
implantation.(Härkönen 
et al., 2017) 
Prospective 
cohort study 
Disyllabic, phonetically 
balanced Finnish words in 
noise (validated for 
adults) 
Glasgow 
Benefit 
Inventory 
(GBI); 
Speech, 
Spatial and 
Qualities of 
Hearing Scale 
(SSQ) 
Pre-operatively; 
1-month post-
op;  
average of 
3.6yrs post-op 
(range 1.7-5.1 
yrs post-op) 
Hybrid CI with 
contralateral hearing 
aid (x6 subjects); 
Bilateral hybrid CIs 
(x2 subjects) 
Mean LF hearing 
threshold decline 125-
500Hz in the 
implanted and non-
implanted ear;  
Total loss of residual 
low-frequency hearing 
after implantation. 
Lenarz, T., et al. (2013). 
European multi-centre 
study of the Nucleus 
Hybrid L24 cochlear 
implant. (Lenarz et al., 
2013) 
Prospective 
study, with 
sequential 
enrollment 
and within-
subject 
comparisons. 
Speech recognition in 
quiet and noise using 
disyllabic and 
monosyllabic words in 
local languages (France 
[Fournier lists, 20 items], 
Italy [GN Resound 2000, 
20 items] and Spain 
[University of Navarra, 
Adult, 25 items]. Lists of 
monosyllabic words were 
used in Belgium [NVA, 
40 items], Germany 
Speech and 
spatial 
qualities scale 
(SSQ); 
Healthy 
Utility Index 
mk3 (HUI) 
Pre-operatively; 
1-month post-
op;  
3 months’ post-
op;  
6 months’ post-
op;  
12 months’ 
post-op 
(1) Hybrid CI alone  
(2) Best aided 
condition using 
hybrid CI 
Completely conserved 
(defined as: less than 
or equal to 10 dB 
threshold increase); 
Partially or 
completely conserved 
(defined as: less than 
or equal to 30 dB 
threshold increase) 
[at one month and 
one-year post-
implantation] 
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[Freiburg monosyllables, 
20 items], the Netherlands 
[NVA, 20 items] and 
United Kingdom [AB 
words, 20 items]) 
Roland, J. T., et al. 
(2016). United States 
multicenter clinical trial 
of the cochlear nucleus 
hybrid implant system: 
Nucleus Hybrid Implant 
System Clinical Trial. 
(Roland et al., 2016) 
Prospective, 
single-arm 
repeated 
measures, 
single-subject 
design 
CNC words; AzBio 
sentences in noise 
Speech, 
Spatial and 
Qualities of 
Hearing Scale 
(SSQ) 
Pre-operatively; 
1-month post-
op;  
3 months’ post-
op;  
6 months’ post-
op;  
12 months’ 
post-op 
(1) Hybrid system 
with contralateral ear 
plugged to mitigate 
contribution 
(2) Hybrid system in 
combination 
with acoustic hearing 
in the opposite, un-
implanted ear. 
Profound hearing loss 
(greater than 
90dBHL);  
Functional acoustic 
hearing (less than or 
equal to 90dBHL) 
Roland, J. T., et al. 
(2018). Long-term 
outcomes of cochlear 
implantation in patients 
with high-frequency 
hearing loss: Long-Term 
Electric-Acoustic 
Hearing Outcomes. 
(Roland et al., 2018) 
Retrospective 
study of 
compiled data 
from related 
clinical 
studies 
CNC in quiet Speech, 
Spatial and 
Qualities of 
Hearing Scale 
(SSQ)  
Pre-operatively; 
1 yr post-op;  
3 yrs post-op;  
5 yrs post-op 
(1) Best unilateral 
condition [hybrid if 
possible or total 
electric]  
(2) Best bilateral 
condition [hybrid+ 
HA in contra ear or 
bimodal] 
Functional residual 
hearing (defined as: 5 
frequency LF PTA 
[125-1kHz] greater 
than or equal to 90 
dBHL);  
Measurable hearing 
(defined as: any 
measurable threshold 
within that frequency 
range);  
Total Loss (defined 
as: no measurable 
thresholds at the limits 
of the audiometric 
equipment) 
 
Santa Maria, P. L., et al. 
(2013). Hearing 
Preservation Surgery 
for Cochlear 
Implantation—Hearing 
and Quality of Life 
After 2 Years. 
(Santa Maria et al., 
2013) 
Retrospective 
cohort study 
 
BKB sentences in quiet; 
CNC words in quiet; BKB 
SIN 
Abbreviated 
Profile of 
Hearing Aid 
Benefit 
(APHAB); 
Glasgow 
Hearing Aid 
Benefit 
Pre-operatively; 
<3 months’ 
post-op;  
6-12 months’ 
post-op;  
12-24 months’ 
post-op;  
>2 yrs post-op 
EAS condition if 
hearing was 
preserved;  
CI only condition if 
not preserved 
Complete hearing 
preservation (0-25%); 
Partial hearing 
preservation (25-
60%);  
Minimal hearing 
preservation (>60%); 
Complete loss of 
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(GHABP 
Scales) 
hearing (no 
measurable hearing) 
Skarzynski, H., et al. 
(2014). Cochlear 
Implantation with the 
Nucleus Slim Straight 
Electrode in Subjects 
with Residual Low-
Frequency Hearing. 
(Skarzynski et al., 2014) 
Prospective 
study, with 
sequential 
enrollment 
and within-
subject 
repeated 
measures.  
Polish monosyllabic 
words in quiet; Polish 
monosyllabic words in 
noise (+10dB SNR) 
-- Pre-operatively; 
1-month post-
op;  
4 months’ post-
op;  
7 months’ post-
op;  
1-year post-op 
(1) Pre-operatively 
tested aided and 
unaided 
(2) Post-operatively 
tested with hybrid 
processor and with or 
without HA in 
contralateral ear 
Hearing preservation 
at 500Hz 
(1) preserved within 
10dB of pre-op values 
(2) preserved within 
30dB of pre-op values 
  
Usami, S.-I., et al. 
(2014). Hearing 
preservation and clinical 
outcome of 32 
consecutive electric 
acoustic stimulation 
(EAS) surgeries. 
(Usami et al., 2014) 
Prospective 
study 
Speech 
discrimination (using the 
67S Japanese 
monosyllable 
test); Monosyllable 
speech perception; word 
perception; sentence 
perception (using the 
Japanese CI2004 
monosyllable, word and 
sentence test);  
 
-- Pre-operatively; 
1-month post-
op;  
3 months’ post-
op;  
6 months’ post-
op;  
12 months’ 
post-op 
(1) Hearing 
aid alone 
(2) CI alone 
(3) Combined EAS 
Average change in 
threshold 125-1000Hz 
from pre-op to 1-
month post-op 
BKB-SIN: Bamford-Kowal-Bench Speech-in-Noise test; BKB sentences: Bamford-Kowal-Bench sentences; CI: Cochlear implant; contra: contralateral; CNC 
words: Consonant- Nucleus- Consonant words; CUNY: City University of New York; HA: Hearing Aid 
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Subject Characteristics 
Table 2 displays the demographic and historical characteristics of the subjects included in 
all 10 studies. Total overall sample size across the 10 studies was 326 subjects with an average 
sample size of 32.6 subjects. Studies ranged in sample size from 6 to 68 participants. The 
following subject characteristics were extracted when possible: Age at implantation and subject’s 
age range, gender split, duration of hearing loss (as defined by study), etiology of subject’s 
hearing loss, cochlear implant manufacturer and type. The average age of implantation across all 
studies was 52.92 years and the age range was 15 to 86.2 years. It should be noted that one 
subject from Skarzynski et al., 2014 fell outside the specified criteria of 18 years and older. As 
no individual information could be extracted from the study regarding this subject, he or she was 
included in this review. Given the proximity to the inclusion age, it is unlikely the inclusion of 
this subject affected the findings. Excluding this subject, the youngest participant was 19.6 years 
old. Average gender split revealed 204 female subjects and 122 male subjects, making the 
majority of participants female. Duration of subject’s hearing loss was reported in 9 of 10 
studies. Determining adult subject’s exact duration of hearing loss is difficult as at the age of 
diagnosis, the hearing loss is often already longstanding, hence the definition of “duration of 
hearing loss” varied dramatically. The average duration was 23.6 years with shortest average 
duration being 11.3 years in Carvalho et al., 2013 and longest average duration being 37 years in 
Adunka et al., 2013. Etiology of hearing loss was reported individually for all subjects with the 
exception of 1 study (Usami et al., 2014), however, by far the most reported etiology was 
“unknown”. 6 of the 10 studies reported “unknown” as the most common etiology. Similarly, in 
3 of 10 studies, more than 50% of the subject’s etiology was “idiopathic”. It can be concluded 
that for the majority of the subjects included in this study, the onset of hearing loss did not have a 
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specific etiology or cause. Other etiologies included hereditary/familial/genetic, noise induced 
hearing loss, presbycusis, ototoxicity/chemotherapy, otosclerosis, autoimmune disease, fever, 
measles, and inner ear disease. Exact percentages of subjects with these etiologies can be found 
in Table 2. Implants used in this study came from either Cochlear Americas (6 studies) or Med-
El (4 studies). Advanced Bionics was the only cochlear implant manufacturer currently in 
circulation that was not included in the given studies (note: at the time of data collection for the 
studies in this review, Oticon Medical cochlear implants were not being distributed in the United 
States). Of the 6 studies utilizing Cochlear America’s implant systems, 5 used the Cochlear 
Nucleus L24 electrode array. The 6th study, Skarzynski et al., 2014, utilizes the Cochlear 
Nucleus Slim Straight electrode array (Nucleus CI422). Gantz et al., 2016 also included the 
Cochlear Nucleus S8 electrode array in specific subjects. The Med-El FLEX24, also called the 
FLEXEAS, was used in all 4 studies which utilized Med-El devices. Other Med-El electrode 
arrays used were the PulsarCi, SonataTi, FLEXSOFT, and Combi40+.  
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Table 2: Subject Characteristics 
Study Sample Size Average Age at 
Implantation/ 
Age Range 
Gender Split Duration of 
Hearing Loss 
Etiology of 
Hearing Loss 
Implant Type 
Adunka, O. F., et al. (2013). 
Hearing preservation and speech 
perception outcomes with electric-
acoustic stimulation after 12 
months of listening experience: 
Hearing Preservation and Speech 
Perception Outcomes with EAS.  
(Adunka et al., 2013) 
18 55 yrs; 20.2-76.6 
yrs 
38.9% 
female; 
61.1% male 
37.0 ± 17.6 yrs 
[defined as first 
hearing aid 
fitting] 
Idiopathic (50%); 
noise induced 
hearing loss 
(22.2%);  
hereditary (22.2%); 
unknown (5.5%) 
Med-El DUET EAS 
speech processor; 
PulsarCi, SonataTi, 
L24 (EAS) 
electrode array  
Carvalho, G. M. et al. (2013). 
Hearing Preservation after 
Cochlear Implantation: 
UNICAMP Outcomes. 
(Carvalho et al., 2013) 
6 47 yrs; 29-63 yrs 17% female; 
83% male 
11.3 yrs (range 
of 5 to 20 yrs) 
Idiopathic (x6; 
100%) 
Med-El Flex24 (EAS) 
electrode 
Gantz, B. J., et al. (2016). 
Multicenter clinical trial of the 
Nucleus Hybrid S8 cochlear 
implant: Final outcomes: S8 
Hybrid Cochlear Implants. 
(Gantz et al., 2016) 
68 58.8 yrs; 19.6-
82.3 yrs 
55.2% 
female; 
44.8% male 
 
26 ± 13.4 yrs 
 
Unknown (47.1%); 
hereditary (25.3%); 
noise exposure 
(17.2);  
inner ear disease 
(2.3%);  
measles (2.3%); 
other (1.1%) 
 
Cochlear Nucleus 
Hybrid™ S8; 
Nucleus Flex24 
(EAS), Nucleus 
Freedom Processor 
 
Härkönen, K., et al. (2017). 
Hybrid cochlear implantation: 
quality of life, quality of hearing, 
and working performance 
compared to patients with 
conventional unilateral or 
bilateral cochlear implantation. 
(Härkönen et al., 2017) 
8 49 yrs; 25-70 yrs 62.5% 
female; 
37.5% male 
-- Unknown (x8) Cochlear Nucleus 
Hybrid L24 (EAS) 
Lenarz, T., et al. (2013). European 
multi-centre study of the Nucleus 
Hybrid L24 cochlear implant. 
(Lenarz et al., 2013) 
66 53.46 yrs; 21-81 
yrs 
79% female; 
21% male 
13.4 ± 12.2 yrs 
[defined as 
duration of 
severe/profound 
high frequency 
HL] 
Unknown (54%); 
familial (19%); 
ototoxicity (6%); 
otosclerosis (3%); 
other (18%) 
Cochlear Nucleus 
Hybrid L24 (EAS) 
and Freedom SP 
processor 
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Roland, J. T., et al. (2016). United 
States multicenter clinical trial of 
the cochlear nucleus hybrid 
implant system: Nucleus Hybrid 
Implant System Clinical Trial 
(Roland et al., 2016) 
50 61.1 yrs; 23 to 
86.2 yrs 
50% female; 
50% male  
28.1 ± 14.9 yrs 
[overall hearing 
loss];  
13.1 ± 7.2 yrs 
[high frequency 
hearing loss] 
Unknown (50%); 
noise exposure 
(22%);  
familial (20%); 
other (8%) 
Cochlear Nucleus 
Hybrid L24 (EAS) 
Implant and processor 
Roland, J. T., et al. (2018). Long-
term outcomes of cochlear 
implantation in patients with 
high-frequency hearing loss: 
Long-Term Electric-Acoustic 
Hearing Outcomes.  
(Roland et al., 2018) 
32 62.3 yrs; 23-86.2 
yrs 
53% female; 
47% male 
26.5 ± 12.1 yrs 
[overall hearing 
loss];  
13.6 ± 7.2 yrs 
[severe/ 
profound high 
frequency 
SNHL’ 
Unknown (47%); 
noise exposure 
(28%);  
familial (19%); 
autoimmune (3%); 
fever (3%) 
Cochlear Nucleus 
Hybrid L24 (EAS) 
Implant and processor 
Santa Maria, P. L., et al. (2013). 
Hearing Preservation Surgery for 
Cochlear Implantation—Hearing 
and Quality of Life After 2 Years 
(Santa Maria et al., 2013) 
13 51 yrs; 32-72 yrs 57% female; 
43% male 
25 yrs (range of 
5- 62 yrs) 
Idiopathic (57%); 
hereditary (21%); 
genetic (7%); 
presbycusis (7%); 
chemotherapy (7%) 
Med-EL Flex 24 
(EAS) electrode & 
Duet 2 processor  
Skarzynski, H., et al. (2014). 
Cochlear Implantation with the 
Nucleus Slim Straight Electrode 
in Subjects with Residual Low-
Frequency Hearing 
(Skarzynski et al., 2014) 
Group 
A 
11 45.5 yrs;  
15-84 yrs [all 
subjects]* 
73% female; 
27% male 
25.1 ± 12.8 yrs Unknown (69%); 
familial (11%); 
noise induced 
(6%);  
other (14%) 
Cochlear Nucleus 
Slim Straight array 
(Nucleus CI422) & 
Nucleus Freedom 
sound processor 
Group 
B 
13 45.2 yrs 77% female; 
23% male 
14.4 ± 8.6 yrs 
Group 
C 
11 41.4 yrs 91% female; 
9% male 
21.1 ± 10.1 yrs 
Usami, S.-I., et al. (2014). Hearing 
preservation and clinical outcome 
of 32 consecutive electric acoustic 
stimulation (EAS) surgeries  
(Usami et al., 2014) 
30 47.5 yrs; 21-71 
yrs 
66.7% 
female; 
33.3% male 
25 yrs (range of 
3-52 yrs) 
Genetic 
heterogeneity 
involved for all 
subjects; no 
individual 
etiologies reported.  
Med-El PULSAR 
with 24 mm FLEX 24 
(EAS) device (x27); 
FLEXSOFT electrode 
(x2);  
Combi40+ with 
standard electrode 
(x1) 
*Denotes subject falls outside of specified criteria; subject could not be removed from data due to limited information from study 
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Speech Recognition Outcomes 
Table 3 displays the speech recognition outcomes reported for subjects in the included 
studies. Primary speech outcome measures and materials are listed again for reference as 
previously noted in Table 1. Outcomes are displayed as pre-operative scores as compared to 
post-operative scores at several follow-up time intervals whenever possible. 4 of the studies did 
not specify actual pre-operative scores but instead reported findings in terms of mean changes 
and differences, benefit percentage points, or post-operative scores only. Some of these studies 
did obtain pre-operative scores, but findings were only displayed in tables or graphs and 
therefore exact data could not be extracted. Significant improvements in speech scores pre- to 
post- operatively were denoted with a “*” in the post-op findings column (p<0.05 or less). If the 
finding was not marked with “*”, then the finding was either insignificant or was not specified. 
Impression of the finding will be indicated in the significant findings column. Other outcomes 
noted in this table include a comparison of EAS verses non- EAS user comparisons. In 9 of 10 
studies, researchers included some kind of comparison between the use of the acoustic 
component in an EAS system and the use of the CI alone. This comparison may include the 
differences between subjects using a traditional CI and those using a Hybrid Device, or a within-
subjects’ comparison of EAS use as compared to no EAS use. Lastly, significance findings were 
extracted from each study and were summarized in the final column of the Table 3. If a study did 
not state statistical significance, then the overall finding or impression was noted.  
The most common speech measure that was used and extracted from the included studies 
was CNC words. CNC words consist of open set word lists of monosyllabic words, in which the 
structure of consonant- nucleus- consonant is maintained. It is considering the gold standard in 
testing cochlear implant candidacy and is therefore frequently used as a pre-operative verses 
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post-operative comparison in this review (Bierer et al., 2016). While all studies included 
measurement points up to at least 12 months, exact post-operative scores at the 12-month mark 
were not always reported. For that reason, the exact post-operative scores at earlier follow-up 
points are reported in Table 3. As previously stated, 5 of 10 studies utilized CNC words as one of 
their speech perception outcome measures. 4 of these 5 studies reported both pre-operative and 
post-operative scores. Adunka et al., 2013 reported a mean pre-operative score of 23.1%, with 
post-operative scores recorded at 65.1% at 3 months, 69.1% at 6 months, and 70.7% at 12 
months. All post-operative follow-up points revealed significant improvements in scores from 
pre- to post-op. Roland et al., 2016 reported a mean pre-operative score of 28.4%, with a post-
operative score of 64.2% at 6 months. Similar findings were noted for 3 month and 12 month 
follow up intervals. All post-operative follow-up points revealed significant improvements in 
scores from pre- to post-op. Similarly, in Roland et al., 2018, a mean pre-operative score of 
27.7% was reported with post-operative scores obtained at 73.4% at 12 months, 69.1% at 3 
years, and 70.4% at 5 years. All post-operative follow-up points revealed significant 
improvements in scores from pre- to post-op. In Santa Maria et al., 2013, scores were reported 
for the implanted ear alone and in the bilateral condition. In the implanted ear alone, pre-
operative scores were obtained at 15.42%, with early post-op scores at 54.5% and late post-op 
scores at 45.83%. In the bilateral condition, pre-operative scores were obtained at 20.29%, with 
early post-op scores at 64% and 40%. Significant improvements were noted pre- to post-op at 
both follow-up intervals in both conditions. In the 5th study which included CNC words, Gantz et 
al., 2016, findings were reported as signficant differences pre- to post-operatively. 87% of 
subjects had significant improvements pre- to post-op in the hybrid cochlear implant with a 
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contralateral hearing aid condition. 82.5% of subjects had significant improvements pre- to post-
op in the hybrid cochlear implant alone condition.  
Other speech perception tests performed in quiet included the BKB sentences in quiet. 
With this measure, Santa Maria et al., 2013 obtained a pre-operative score of 62.8%, with an 
early post-op score of 88.5% and a late post-op score of 80% in the implanted ear alone 
condition. In the bilateral condition, a pre-op score of 68.4%, a early post-op score of 97.3%, and 
a late post-op score of 80.3% were obtained. Both findings were statistically significant. Several 
studies utilizes speech perception tests in the local languages. Skarzynski et al., 2014, using 
Polish monosyllabic words in quiet, obtained mean pre-operative scores at 35.6%. Post operative 
scores were not reported, but significant improvements were noted. It was also reported that 71% 
of subjects obtained >20 percentage point gains in word scores. Lenarz et al., 2013 did not note 
pre-operative scores but reported a mean benefit of 32 percentage points for the hybrid cochlear 
implant ear, which was significant, using disyllabic and monosyllabic words in local languages. 
Usami et al., 2014 utilized a speech discrimination test in the local language and obtained a pre-
operative score of 24.1% and a post-operative score of 67.4% at 12 months which was 
statistically significant. Carvalho et al., 2013 utilized a speech perception test based on test 
developed by Bevilacqua et al. from several English language tests. An average pre-operative 
score for all subjects was obtained at 7.67% and 4.5% for EAS users only. Post-operative scores 
were obtained at 63.67% and 72% for all subjects and EAS subjects, respectively. Härkönen et 
al., 2017 assessed speech discrimination in quiet and speech perception in noise using disyllabic 
Finnish words. No pre-operative scores were reported but they noted an 88% speech 
discrimination score and approximately 82% correct at 0dB SNR post-operatively.   
Several speech in noise tests were also conducted to determine benefit pre to post-
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operatively. BKB-SIN is a speech in noise test used in 2 of the studies. Gantz et al., 2016 did not 
note pre-operative scores but reported significant changes pre-operatively to post-operatively in 
the hybrid cochlear implant with contralateral hearing aid condition and in the hybrid cochlear 
implant alone condition. Minimal or non-significant improvements were noted in the electric- 
only condition. Santa Maria et al., 2013 also utilized BKB-SIN with a score of 9.75 pre-
operatively and 7.6 post-operatively which was not significant. Adunka et al., 2013 utilized the 
CUNY sentences in noise with mean pre-operative score obtained at 15.1%, and post-operative 
scores obtained at 23.8% at 3 months, 18.4% at 6 months and 21.5% at 12 months. All score 
improvements were significant. Roland et al., 2016 reported AzBio sentences in noise with pre-
operative scores of 16.3% and post-operative scores of 48.3% in the implanted ear alone at all 
follow-up intervals. A significant improvement of 33 percentage points in the bilateral condition 
was also noted. Usami et al., 2014 employed several speech in noise measures including 
monosyllable perception in noise, word perception in noise, and sentence perception in noise. 
Pre-operative scores were obtained at 21%, 35.8% and 51.3% and post-operatively at 60.2%, 
77%, and 88.2% at 12 months, respectively for the previously stated measures. Skarzynski et al., 
2014 utilized monosyllabic words in noise but did not report pre-operative scores. They reported 
signficiant improvments in scores pre- to post-operatively and 91% of subjects obtained >20 
percentage point gains in word scores in noise. Lenarz et al., 2013 also did not report pre-
operative findngs for speech recognition in noise using disyllabic and monosyllabic words in 
local languages. Post-operatively, a mean benefit of 42 percentage points for the hybrid cochlear 
implant ear was found, which was significant. Also, 73% of subjects improved their speech 
recognition score in noise by ³20 percentage points or ³2 dB SNR. In summary, significant pre-
to post-op improvements were found in all studies which reported significance. Of those studies 
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that did not report significance, considerable improvements were found.   
9 of the 10 studies also included a comparison of EAS and non-EAS users to determine 
the benefit of including an acoustic stimulation of low frequencies, along with the traditional 
electric stimulation of the high frequencies. 5 of these 9 studies included a within-subjects’ 
comparison of performance with and without use of the acoustic component. These subjects 
utilized electric stimulation alone without the benefit of acoustic hearing and scores were 
compared. Adunka et al., 2013, Gantz et al., 2016 and Usami et al., 2014 all reported 
significantly better performance in speech outcome measures using the EAS component as 
compared to use of electric stimulation alone. Skarzynski et al., 2014 had similar findings when 
testing in noise, but these improvements were not significant in the quiet condition. Lenarz et al., 
2013 reported that the use of the acoustic component of the hybrid cochlear implant resulted in 
an average benefit of 20 percentage points or 2dB SNR in quiet and in noise as compared to 
cochlear implant alone, however no significance finding was noted. One study performed a 
between-subjects’ comparison of EAS use. Härkönen et al., 2017 noted that hybrid cochlear 
implant subjects performed better in speech perception tasks as compared to bilateral cochlear 
implant and bimodal cochlear implant subjects, but the differences between hybrid cochlear 
implant with a contralateral hearing aid subjects and the bilateral cochlear implant subjects were 
not significant. The remaining 3 studies which reported comparisons found no significant 
differences between those subjects who used EAS and those who did not. Santa Maria et al., 
2013 found that there were no significant differences between those using EAS and those no 
longer using EAS in any speech outcome or subjective measure. Those who no longer used EAS 
either lost residual hearing post implantation or chose to discontinue use. Carvalho et al., 2013 
found that there were no notable differences between users of EAS and non-EAS users. Roland 
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et al., 2016 stated that of the 7 subjects who lost residual hearing, but continued to use the 
implanted device with electric-only along with a hearing aid in the contralateral ear, had average 
bilateral CNC word scores in quiet that were statistically similar to hybrid subjects able to use 
acoustic hearing in both ears. Overall, significant pre- to post-operative findings were noted in all 
studies and the use of EAS also proved to be of significant benefit in the majority of the studies.  
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Table 3: Speech Recognition Outcomes 
 
Study Speech 
Outcome 
Measures 
Pre-op Findings  
(mean, unless 
otherwise noted) 
Post-op Findings EAS user vs Non-EAS 
User Comparison 
Significance Findings 
 
Adunka, O. F., et al. 
(2013). Hearing 
preservation and speech 
perception outcomes 
with electric-acoustic 
stimulation after 12 
months of listening 
experience: Hearing 
Preservation and 
Speech Perception 
Outcomes with EAS. 
(Adunka et al., 2013) 
CNC words in 
quiet (EAS 
condition only) 
23.1 ± 6.8%. 3 mo 
65.1 ± 
13.1%* 
6 mo 
69.1 ±  
15.3%* 
12 mo 
70.7 ±  
11.7%* 
All subjects showed 
improved scores using 
EAS over CI alone in 
all measures, at all time 
intervals.  
-Subjects had significant 
improvements in scores 
for CNC words and 
CUNY sentences pre- to 
post-op. 
 
-Better scores noted for 
EAS condition over CI 
alone condition for all 
subjects, in all measures, 
at all time intervals. 
Significance was not 
reported 
CUNY 
sentences in 
noise 
15.1 ± 11.3%. 61.7 ± 
23.8%* 
66.6 ± 
18.4%* 
72.2 ± 
21.5%* 
Carvalho, G. M. et al. 
(2013). Hearing 
Preservation after 
Cochlear Implantation: 
UNICAMP Outcomes. 
(Carvalho et al., 2013) 
Speech 
perception test 
[based on test 
developed by 
Bevilacqua et al. 
from several 
English 
language tests] 
 
All subjects- 7.67% 
EAS users only- 
4.5% 
All subjects- 63.67% 
EAS users only- 72% 
No notable differences 
between EAS and non- 
EAS users 
Overall improvement 
between pre- and post-op 
scores. Significance 
findings not reported. 
Gantz, B. J., et al. 
(2016). Multicenter 
clinical trial of the 
Nucleus Hybrid S8 
cochlear implant: Final 
outcomes: S8 Hybrid 
Cochlear Implants. 
(Gantz et al., 2016) 
CNC words in 
quiet 
Pre-operative scores 
not reported; findings 
reported in changes 
over time 
Hybrid CI + Contra HA 
87% of subjects had 
significant improvements 
pre- to post-op* 
-Subjects were 
compared in 3 
conditions; CI only 
(electric), hybrid CI 
only, and hybrid CI + 
HA in contralateral ear. 
Subjects showed 
significant 
improvement in CNC 
and BKB-SIN scores in 
-Subjects experienced 
significant improvements 
in CNC and BKB scores 
pre- to post-op in both the 
hybrid CI and hybrid 
CI+HA conditions 
 
-Subjects yielded the 
greatest significant 
improvements in CNC and 
Hybrid CI 
82.5% of subjects had 
significant improvements 
pre- to post-op* 
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CI (electric only) 
60% of subjects had 
significant improvements 
pre- to post-op* 
both the hybrid CI and 
hybrid CI+ HA 
condition. Non-
significant changes 
were noted in the CI 
only condition 
 
- Greatest 
improvements were 
noted in the hybrid 
CI+HA condition 
 
-No significant changes 
noted pre- to post-op 
for the CI condition 
(electric only) on BKB-
SIN  
BKB-SIN scores pre- to 
post- op in the hybrid CI+ 
HA condition over all 
other conditions with no 
significant difference in 
the CI only condition. BKB SIN Pre-operative scores 
not reported; findings 
reported in changes 
over time 
Hybrid CI + Contra HA 
Significant changes noted 
pre- to post-op (P < .0001)* 
Hybrid CI 
Significant changes noted 
pre- to post-op (P < .0001)* 
CI (electric only) 
Minimal/ non-significant 
improvements noted pre- to 
post-op 
Härkönen, K., et al. 
(2017). Hybrid cochlear 
implantation: quality of 
life, quality of hearing, 
and working 
performance compared 
to patients with 
conventional unilateral 
or bilateral cochlear 
implantation.(Härkönen 
et al., 2017) 
Speech 
discrimination 
in quiet using 
disyllabic 
Finnish words 
Pre-operative scores 
not reported; findings 
reported in figures 
88% speech discrimination 
 
-Hybrid CI subjects 
performed better in 
speech perception tasks 
as compared to bilateral 
CI and bimodal CI 
subjects. 
 
-Differences between 
hybrid CI + contra HA 
subjects and bilateral CI 
subjects were not 
significant 
-Subjects experienced 
improvements in speech 
discrimination scores, but 
nothing can be said 
regarding its significance 
 
- Findings indicate 
subjects with hybrid CI + 
contra HA score better 
than bilateral CI subjects, 
however, this difference is 
not significant 
Speech 
perception in 
noise using 
disyllabic 
Finnish words 
Pre-operative scores 
not reported; findings 
reported in figures 
Approximately 82% correct 
at 0dB SNR (exact number 
not reported) 
 
Lenarz, T., et al. (2013). 
European multi-centre 
study of the Nucleus 
Hybrid L24 cochlear 
implant. (Lenarz et al., 
2013) 
Speech 
recognition in 
quiet using 
disyllabic and 
monosyllabic 
words in local 
languages  
Pre-operative scores 
not reported; findings 
reported in benefit 
percentage points 
-Mean benefit of 32 
percentage points for the 
hybrid CI ear* 
 
-Mean benefit of 28% points 
for the best aided condition* 
 
-70% of subjects improved 
their speech recognition score 
in noise by _³20 percentage 
points in CI ear 
-Use of the acoustic 
component of the 
hybrid CI resulted in an 
average benefit of 20 
percentage points or 
2dB SNR in quiet and 
in noise as compared to 
CI alone (electric only). 
 
- For 12% of subjects 
CI only and hybrid 
-Subjects experienced a 
significant improvement 
in speech recognition in 
quiet and in noise pre- to 
post-op 
 
-Use of EAS resulted in a 
substantial benefit for 
subjects in speech and in 
noise 
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Speech 
recognition in 
noise using 
disyllabic and 
monosyllabic 
words in local 
languages 
Pre-operative scores 
not reported; findings 
reported in benefit 
percentage points 
-Mean benefit of 42 
percentage points for the 
hybrid CI ear* 
 
-Mean benefit of 38% points 
for the best aided condition* 
 
-73% of subjects improved 
their speech recognition score 
in noise by _³20 percentage 
points or ³2 dB SNR 
conditions resulted in 
equal scores 
Roland, J. T., et al. 
(2016). United States 
multicenter clinical trial 
of the cochlear nucleus 
hybrid implant system: 
Nucleus Hybrid 
Implant System Clinical 
Trial. (Roland et al., 
2016) 
CNC words 28.4%± 14.7% 6 mo post-op 
Implanted ear 
64.2% ±  26.6%* 
similar findings noted for 3 
month and 12 month follow-
up intervals* 
Of the 7 subjects who 
lost residual hearing but 
continued to use the 
implanted device, 
electric-only (along 
with a hearing aid in the 
contralateral ear), 
average bilateral CNC 
word scores in quiet 
were statistically 
similar to hybrid 
subjects able to use 
acoustic hearing in both 
ears * 
-96% and 90% of subjects 
performed equal or better 
on CNC words and AzBio 
sentences as compared to 
pre-operative scores.  
 
-All subjects had a 
significant improvement 
in CNC words and AzBio 
sentences pre- to post-op 
 
-Significant improvements 
were also found in the 
bilateral (EAS+ HA in 
contralateral ear) 
condition 
 
-EAS and non-EAS users 
has statistically similar 
CNC word scores in quiet 
Bilateral 
Improvement of 34.7 
percentage points 
(SD=17.4)* 
AzBio sentences 
in noise 
16.3% ±  14.4% Implanted ear 
48.3% ±  31.3%* 
similar findings noted for 3 
month and 12 month follow-
up intervals* 
Bilateral 
Improvement of 33 
percentage points 
(SD=23.5)* 
Roland, J. T., et al. 
(2018). Long-term 
outcomes of cochlear 
implantation in patients 
CNC in quiet Unilateral  
27.7% 
12 mo 
73.4%* 
3 yrs 
69.1%* 
5 yrs 
70.4%* 
-- -Subjects experienced 
significant improvements 
in CNC scores pre-op to 
post-op.  
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with high-frequency 
hearing loss: Long-
Term Electric-Acoustic 
Hearing Outcomes. 
(Roland et al., 2018) 
Bilateral 
45.8% 
 
83.5%* 
 
80.3%* 
 
80.4%* 
-No significant changes in 
scores from the 12 month 
point other measurement 
intervals  
Santa Maria, P. L., et 
al. (2013). Hearing 
Preservation Surgery 
for Cochlear 
Implantation—Hearing 
and Quality of Life 
After 2 Years. 
(Santa Maria et al., 
2013) 
BKB sentences 
in quiet 
Implanted ear 
62.8% 
Early post-op 
88.5%* 
Late post-op 
80%* 
 
There were no 
significant differences 
between those using 
EAS and those no 
longer using EAS in 
any speech outcome or 
subjective measure 
-All subjects had a 
significant improvement 
in BKB sentences and 
CNC words pre- to post-
op 
 
-Overall, subjects had a 
better signal to noise ratio 
post-op on BKB SIN. No 
significant positive 
changes were noted. 
 
-No significant differences 
in speech outcomes 
between EAS and non-
EAS users  
Bilateral 
68.4% 
 
97.3%* 80.8% 
CNC words in 
quiet 
Implanted ear 
15.42% 
 
54.5%* 
 
45.83%* 
Bilateral 
20.29% 
 
64%* 40%* 
BKB SIN (EAS 
users only n=4) 
9.75 7.6 
Skarzynski, H., et al. 
(2014). Cochlear 
Implantation with the 
Nucleus Slim Straight 
Electrode in Subjects 
with Residual Low-
Frequency Hearing. 
(Skarzynski et al., 2014) 
Polish 
monosyllabic 
words in quiet 
Polish  
35.6% Significant improvement in 
word scores pre- to post op* 
 
71% of subjects obtained >20 
percentage point gains in 
word scores 
-Use of EAS + contra 
HA resulted in 
significantly better 
performance in noise as 
compared to CI only + 
contra HA*  
 
-In quiet, improvements 
in scores were non-
significant 
-Subjects achieved 
significant improvement 
in scores for words in 
quiet and words in noise 
 
-Use of EAS as compared 
to electric only CI, 
significantly improved 
word recognition in noise 
but not in quiet 
 
-Subjects with all degrees 
of pre-operative HL 
obtained equal substantial 
gain in quiet, however, in 
noise, subjects with the 
better pre-operative 
hearing achieved greater 
sore gains.   
Monosyllabic 
words in noise 
(+10dB SNR) 
Pre-operative score 
not reported; findings 
reported in mean 
differences 
Significant improvement in 
word scores in noise pre- to 
post op* 
 
91% of subjects obtained >20 
percentage point gains in 
word scores in noise 
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Usami, S.-I., et al. 
(2014). Hearing 
preservation and 
clinical outcome of 32 
consecutive electric 
acoustic stimulation 
(EAS) surgeries. 
(Usami et al., 2014) 
Speech 
discrimination  
 
24.1% 
 
1 month 
48.4% 
 
12 months 
67.4%* 
 
-EAS resulted in the 
significantly better 
performance in speech 
discrimination and 
monosyllable, word, 
and sentence perception 
in noise as compared to 
the acoustic stimulation 
only and electric 
stimulation only 
conditions* 
-Subjects experienced 
significant improvements 
in speech discrimination 
as well as monosyllable, 
word, and sentence 
perception in noise pre- to 
post-op 
  
-Use of EAS significantly 
improved subject’s speech 
discrimination and 
perception abilities over 
electric stimulation or 
acoustic stimulation alone 
 
-Similar results were also 
obtained for those subjects 
with less residual hearing 
Monosyllable 
perception in 
noise 
21.0% 36.9% 60.2%* 
Word perception 
in noise 
35.8% -- 77.0%* 
Sentence 
perception in 
noise 
51.3% -- 88.2%* 
BKB-SIN: Bamford-Kowal-Bench Speech-in-Noise test; BKB sentences: Bamford-Kowal-Bench sentences; CI: Cochlear implant; contra: contralateral; CNC 
words: Consonant- Nucleus- Consonant words; CUNY: City University of New York; HA: Hearing Aid 
*Denotes a significance (p<0.05 or less) finding from pre-op unless otherwise noted 
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Subjective Outcomes 
 
Another outcome measure extracted from the included studies in this review were 
subjective outcome reports. Subjective outcomes refer to the perceived benefit of the subjects 
and are measured based on patient report. 70% (7 of 10) studies reported subjective outcome 
measures using a variety of different materials. The most common measure used was the Speech, 
Spatial and Qualities of Hearing Scale (SSQ), which was utilized in 4 of the 7 studies. The 
questionnaire aims to assess a range of hearing disabilities across 3 domains with particular 
attention given to hearing speech in a competing context, direction and distance of hearing in 
space, and the quality of hearing experience (Gatehouse & Noble, 2004). Roland et al., 2016, 
Roland et al., 2018 and Lenarz et al., 2013 all found significant subjective improvements in 
speech, spatial, and quality subscales pre- to post-operatively for a within-subject comparison. 1 
of the 4 studies which used the SSQ, compared hybrid cochlear implant users to bilateral 
cochlear implant and single-sided deafness (SSD) patients. Härkönen et al., 2017 noted that 
bilateral CI patients experienced significantly better speech intelligibility than hybrid CI or SSD 
patients. This same study also administered the Glasgow Benefit Inventory (GBI) which found 
that subjects experienced significant subjective benefit in general health and overall GBI score 
and that hybrid cochlear implant subjects experienced overall greater significant benefits than 
SSD patients. Subjective benefit was not significant in the social support and physical health 
sub- categories. Other subjective outcome measures included hearing aid benefit questionnaires 
utilized to represent benefit from cochlear implantation. Using the Abbreviated Profile of 
Hearing Aid Benefit (APHAB), Santa Maria et al., 2013 found that subjects experienced 
significant perceived benefit in global benefit, background noise, and reverberation, but non-
significant benefit was noted in ease of communication and aversiveness subscales. The 
differences between EAS and non-EAS users experience were not significant. Gantz et al., 2016 
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reported that subjects had >22% improvement in 3 of 4 subscales; background noise, ease of 
communication, and reverberation. They concluded that subjects experienced significant 
perceived benefit in background noise, ease of communication, and reverberation. Santa Maria et 
al., 2013 also utilized the Glasgow Hearing Aid Benefit Scale (GHABP) which showed high 
levels of use and benefit, as well as low levels of residual disease, but no statement was made for 
the satisfaction subscale. The difference between EAS and non-EAS users was, again, 
insignificant. Lenarz et al., 2013 also included a second subjective outcome measure of the 
Health Utility Index mk3 (HUI). The study indicated that subjects had significant improvements 
in health related quality of life scores. Lastly, Carvalho et al., 2013 utilized a quality of 
experience rating using the Likert scale in which 0 indicated that the user regretted using the CI 
intervention or would not recommend it and 10 indicated that the user was completely satisfied 
with the CI intervention. At the time of reporting, only 4 of 6 subjects utilized EAS. A “*” was 
denoted on individual subjects to indicate that they were not EAS users. All EAS users reported 
an 8 out of 10 or better on the Likert scale suggesting high satisfaction with the CI intervention. 
Overall, subjects experienced significant subjective improvements in a number of subscales and 
contexts across all studies included in this review.  
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Table 4: Subjective Outcome Measures 
 
Study Subjective Outcome Measure Subjective Outcome Score 
(mean changes pre- to post-op unless 
otherwise noted) 
Significance Findings 
Adunka, O. F., et al. (2013). 
Hearing preservation and speech 
perception outcomes with electric-
acoustic stimulation after 12 
months of listening experience: 
Hearing Preservation and Speech 
Perception Outcomes with EAS. 
(Adunka et al., 2013) 
-- -- -- 
Carvalho, G. M. et al. (2013). 
Hearing Preservation after 
Cochlear Implantation: UNICAMP 
Outcomes. 
(Carvalho et al., 2013) 
Quality of experience rating using 
Likert scale 
[0 indicated user regretted the CI 
intervention/would not 
recommend; 10 indicated user was 
completely satisfied with CI 
intervention] 
Subject 1- 9 All EAS users reported an 8 out of 
10 or better on the Likert scale 
suggesting high satisfaction with 
CI intervention 
Subject 2- 6* 
Subject 3- 9* 
Subject 4- 10 
Subject 5- 10 
Subject 6- 8 
Gantz, B. J., et al. (2016). 
Multicenter clinical trial of the 
Nucleus Hybrid S8 cochlear 
implant: Final outcomes: S8 
Hybrid Cochlear Implants. (Gantz 
et al., 2016) 
Abbreviated Profile for Hearing 
Aid 
Benefit (APHAB) 
>22% improvement in 3 if 4 subscales; 
background noise, ease of communication, 
reverberation (reasonable estimate of the 
critical differences at a 90% confidence 
interval) 
Subjects experienced significant 
perceived benefit in background 
noise, ease of communication, and 
reverberation 
Härkönen, K., et al. (2017). Hybrid 
cochlear implantation: quality of 
life, quality of hearing, and 
working performance compared to 
patients with conventional 
unilateral or bilateral cochlear 
implantation.(Härkönen et al., 
2017) 
Glasgow Benefit Inventory (GBI) Mean total GBI score- +44 (p=.012) 
General health- +68 (p=0.011) 
Social support- +2 (not significant) 
Physical health- -10 (not significant) 
Mean total GBI statistically significantly 
higher for hybrid CI patients than for SSD 
patients (p=0.012) 
-Subjects experienced significant 
subjective benefit in general 
health and overall GBI score. 
 
-Hybrid CI subjects experienced 
overall greater significant benefits 
than SSD patients.   
Speech, Spatial and Qualities of 
Hearing Scale (SSQ) 
Subject subscale score; mean change not 
reported 
Speech- 5.4 
Spatial- 5.5 
Quality- 6.2 
Bilateral CI patients experienced 
significantly better speech 
intelligibility than hybrid CI or 
SSD patients. 
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Lenarz, T., et al. (2013). European 
multi-centre study of the Nucleus 
Hybrid L24 cochlear implant. 
(Lenarz et al., 2013) 
Speech and spatial qualities scale 
(SSQ) 
Speech- 1.2 (p<0.001) 
Spatial- 1.3 (p<0.001) 
Quality- 1.8 (p<0.001) 
Subjects experienced significant 
subjective improvements in 
speech, spatial, and quality 
subscales  
Healthy Utility Index mk3 (HUI) Multi-attribute HUI3- +0.117 (p < 0.01, 
effect size Cohen’s d=0.67) 
 
Subjects experienced significant 
improvements in health related 
quality of life scores. 
Roland, J. T., et al. (2016). United 
States multicenter clinical trial of 
the Cochlear Nucleus Hybrid 
implant system: Nucleus Hybrid 
Implant System Clinical Trial. 
(Roland et al., 2016) 
Speech, Spatial and Qualities of 
Hearing Scale (SSQ) 
Speech- 2.2 (SD= 1.8, p<0.001) 
Spatial- .9 (SD= 2.0, p<0.003) 
Quality- 1.3 (SD=2.0, p<0.001) 
Subjects experienced significant 
subjective improvements in 
speech, spatial, and quality 
subscales 
Roland, J. T., et al. (2018). Long-
term outcomes of cochlear 
implantation in patients with high-
frequency hearing loss: Long-Term 
Electric-Acoustic Hearing 
Outcomes. (Roland et al., 2018) 
Speech, Spatial and Qualities of 
Hearing Scale (SSQ)  
Significant pre- to post differences; Actual 
score differences not reported 
Speech- p<.001 for 12 months, 3 years, 
and 5 years post-activation. 
Spatial- p<.001 for 12 months post-
activation; p<0.02 for 3 years and 5 years 
post- activation. 
Quality- p<.001 for 12 months, 3 years, 
and 5 years post-activation. 
 
Subjects experienced significant 
subjective improvements in 
speech, spatial, and quality 
subscales, which remained stable 
across post-activation intervals 
Santa Maria, P. L., et al. (2013). 
Hearing Preservation Surgery for 
Cochlear Implantation—Hearing 
and Quality of Life After 2 Years. 
(Santa Maria et al., 2013) 
Abbreviated Profile of Hearing 
Aid Benefit (APHAB)  
 
Global- 19.87 (p=.02) 
Ease of communication- 22.97 (not 
significant) 
Background noise- 18.13 (p=.03) 
Reverberation- 18.57 (p<.01) 
Aversiveness-2.77 (not significant) 
-Subjects experienced significant 
perceived benefit in global benefit, 
background noise, and 
reverberation.  
 
-Non-significant benefit was noted 
in ease of communication and 
aversiveness subscales. 
 
-Differences between EAS and 
non-EAS users were not 
significant 
Glasgow Hearing Aid Benefit 
(GHABP Scales) 
Mean scores; only measured post-op 
Use- 87.4 
Benefit- 63.3 
Residual disease- 58.6 
Satisfaction- 55.1 
- The GHABP scores showed high 
levels of use, benefit, and low 
levels of residual disease. No 
statement made regarding 
satisfaction 
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- Differences between EAS and 
non-EAS users were not 
significant 
 
Skarzynski, H., et al. (2014). 
Cochlear Implantation with the 
Nucleus Slim Straight Electrode in 
Subjects with Residual Low-
Frequency Hearing. 
(Skarzynski et al., 2014) 
-- -- -- 
Usami, S.-I., et al. (2014). Hearing 
preservation and clinical outcome 
of 32 consecutive electric acoustic 
stimulation (EAS) surgeries. 
(Usami et al., 2014) 
-- -- -- 
*Denotes subjects were not EAS/hybrid users 
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Hearing Preservation Outcomes 
All of the 10 studies in this review included data regarding hearing preservation 
following the implant surgery. Hearing preservation was a topic of discussion in all of the studies 
as the degree of preserved hearing determined the ability to use electric acoustic stimulation with 
a hybrid implant system. Hearing preservation in all studies was in reference to the ability to 
maintain thresholds of hearing in the low frequency range, typically between 125-1000Hz. Going 
forward, discussion of hearing preservation is in reference to this low frequency hearing range. 
Table 5 displays extracted information regarding hearing preservation in the 10 studies. As each 
of the studies specified different amounts of hearing preservation, defined degrees were included 
in this table for ease of reference as previously stated in Table 1. Extracted information included 
the mean pre-operative low frequency pure tone average (LF PTA), the post-operative low 
frequency pure tone average specified by frequency and/or follow-up interval, the percentage of 
subjects who maintained some degree of functional or partial hearing preservation, and the 
number of subjects who experienced a total loss or non-functional loss of hearing. Lastly, 4 of 
the 10 studies included subject’s continued use of the EAS system at least one-year post-
implantation.  
Low frequency pure tone averages were reported in a number of ways. Adunka et al., 
2013, Gantz et al., 2016, Härkönen et al., 2017, and Lenarz et al., 2013 reported the mean low 
frequency pure tone average for all subjects. Mean low frequency PTA was 44.7dB HL, 48.9dB 
HL, 18dB HL, and 46.7 dB HL for the stated studies, respectively. Skarzynski et al., 2014, 
Usami et al., 2014, and Adunka et al., 2013 reported mean low frequency thresholds by 
frequency. Between these studies the mean threshold was 36.6dB HL at 250Hz, 57.25dB HL at 
500Hz, and 86.4dBHL at 1000Hz. These averages follow the general trend of a sharply sloping 
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hearing loss which is of a more mild degree in the lowest freqencies, sloping to more severe 
towards the mid-frequencies. Roland et al., 2016 and Roland et al., 2018 reported low frequency 
PTA by their degree of hearing loss. See Table 5 for specific numbers of subjects in each hearing 
loss category. Santa Maria et al., 2013 reported all subject’s low frequency thresholds were less 
than 65dB at thresholds below 500Hz. Carvalho et al., 2013, due to their small sample size, 
reported average low frequency pure tone average by subject. Averages ranged from 48.3-75dB 
HL.  
 Studies reported hearing preservation in a number of ways in order to demonstrate how 
much hearing was maintained and lost following cochlear implant surgery. Several studies chose 
to report the post-operative low frequency pure tone average to express these changes. Adunka et 
al., 2013 reported a mean low frequency PTA of 44.7dB HL pre-opertively, declining to 60.6dB 
HL one month post-op and 68.5dB HL 12 months post-op, overall concluding that 94.4% of 
subjects maintained at least partial hearing preservation at initial activation. Gantz et al., 2016 
also reported a mean low frequency PTA of 48.9dB HL pre-op, declining to 63.6dB HL at one 
month post-op, further noting that another smaller decline occurred in the first 3 months which 
then stabilized going forward. They stipulated that 94% of the subjects maintained functional 
hearing from 125 to 500 Hz at initial activation. Similarly to these studies, Usami et al., 2014 
reported a mean low frequency PTA of 50.13dB HL pre-op, to 66.15dB HL one month post-op 
and 68.14dB HL 12 months post-op, indicating that 93.3% of subjects maintained sufficient 
residual low frequency hearing for EAS. Härkönen et al., 2017 reported the mean decline in 
hearing in the implanted ear with an average of an 11dB HL decrease in threshold at 125Hz, 
14dB HL at 250Hz, and 19dB HL at 500Hz. Mean low frequency PTA decline was 15dB HL 
post-operatively. At the end of follow-up, researchers concluded that 87.5% of subjects 
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maintained preserved low frequency residual hearing. Similarly, Skarzynski et al., 2014 reported 
that at 1 month post-op, the average low frequency PTA declined by 10dB HL and 15dB HL by 
12 months. This study also noted that at 1 month, 43% of subjects had preserved hearing within 
10dB HL of pre-op values and 86% had preserved hearing within 30dB HL. At 12 months these 
numbers declined with 38% of subjects preserving hearing within 10dB HL and 79% preserving 
within 30dB HL. Overall, 91% of subjects maintained some degree of residual hearing at 1 
month post-op. Additionally, Roland et al., 2016 reported post-op hearing preservation by the 
number of subjects whose low frequency PTA fell within a specified hearing range. Post-
operatively, 15 out of 48 subjects (31.25%) fell in the 41-55dB HL loss range, 9 of 48 subjects 
(18.8%) fell in the 56-70dB HL loss range, and 9 of 48 subjects (18.8%) fell into the 71-90dB 
HL loss range. 66% of subjects maintained residual functional acoustic hearing at 6 months’ 
post-activation. The remaining studies in this review chose to report post-operative low 
frequency thresholds in terms of their own pre-determined degrees of hearing preservation. 
Individal studies defined categories of hearing preservation can be located in Table 1 and again 
in Table 5. Carvalho et al., 2013 stipulated that at initial activation and after more that 1 year 
post-op, 1 subject maintained total hearing preservation, 3 subjects achieved partial hearing 
preservation, 2 subjects experienced hearing preservation failure. This indicated 66.7% of 
subjects maintained some degree of functional hearing for EAS use at the initial activation and 
more than 1 year post-operatively. Lenarz et al., 2013 reported that at 1 month post-op, 61% of 
subject’s hearing was completely conserved and 89% of subject’s hearing was partially or 
completely conserved. At 12 months, 43% of subject’s hearing was completely conserved (-18% 
points) and 74% of subject’s hearing was partially or completely conserved (-15% points). They 
determined that 98% of subjects maintained residual hearing at 500Hz 1-month post-op and 88% 
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maintained residual hearing at 500Hz 12 months post-op. Lastly, Roland et al., 2018 and Santa 
Maria et al., 2013 reported degrees of hearing preservation past the 12 month follow-up period. 
Roland et al., 2018 found that 84.4% of subjects maintained function hearing at 6 months post-
op, 87.5% at 12 months, 87.5% at 3 years, and 87.5% at 5 years. They also noted that the pre- to 
post- operative low frequency pure tone average differences were statistically significant but low 
frequency PTA changes 6 months to 5 years were not statistically significant. Santa Maria et al., 
2013 concluded that hearing preservation somewhat declined over time, however, even by 24+ 
months post-op, 87.5% experienced some degree of hearing preservation.  
All studies reported the number of subjects who experienced a total loss of hearing or not 
enough hearing was preserved to be considered “functional” following the cochlear implant 
surgery. Only one study, Lenarz et al., 2013, reported 0 subjects had a total loss of hearing. 
Remaining studies reported that between 5% and 33.3% of subjects experienced a total or non-
functional loss of hearing. Of the studies which reported specific numbers of subjects rather than 
percentages, between 1 and 16 subjects did not maintain functional hearing. It should be noted 
that the range of these statistics are heavily influenced by sample size. Overall the studies found 
that the vast majority of subjects achieved hearing preservation to varying degrees.  
Lastly, as some subjects historically discontinue use of the EAS system over time, EAS 
usage at > 1 year after activation was reported in 4 of the 10 studies. Generally, subjects may 
choose to discontinue use due to a number of factors. A common reasoning is that the subjects 
had a further decline in hearing in the months following surgery. For that reason, these subjects 
were no longer a candidate for electric acoustic stimulation. In Carvalho et al., 2013, the 4 
subjects who used EAS at activation continued use more than 1 year post op. According to 
Lenarz et al., 2013, 88% of subjects continued use at 1 year post-op. In Roland et al., 2018, EAS 
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usage was reported at 12 months, 3 years, and 5 years post-activation to demonstrate continued 
use over time. Usage was 84%, 81%, and 72%, respectively at the specificed follow-up periods, 
showing a slight but insignificant decline in usage over time. Moreover, Santa Maria et al., 2013 
reported the greasted decline in usage over time with only 6 of 11 patients utilizing EAS at 18 
months after activation. Overall, studies maintained good usage of EAS systems at more than 1 
year after implanation, with the majority of subjects continuing use.   
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Table 5: Hearing Preservation Outcomes 
 
Study LF Hearing 
Preservation 
Defined by 
Study 
Pre-op Low 
Frequency Pure 
Tone Average 
(mean unless 
otherwise 
specified) 
Post-op Low Frequency 
Hearing 
Functional or 
Partial Hearing 
Preservation 
Maintained 
Total or Non- 
Functional 
Hearing Loss 
EAS Usage 
Post-
Activation 
Adunka, O. F., et al. 
(2013). Hearing 
preservation and speech 
perception outcomes with 
electric-acoustic 
stimulation after 12 
months of listening 
experience: Hearing 
Preservation and Speech 
Perception Outcomes 
with EAS. (Adunka et al., 
2013) 
Partial Hearing 
Preservation;  
Total Hearing 
Loss 
44.7 ± 16.5 dB 
HL [MEAN LF 
PTA]; 
32.5 ±12.0 
dB HL [250 Hz]; 
56.4 ± 11.1 dB 
[750Hz] 
1 mo post-op 
60.6 ± 16.1 
dB HL 
[MEAN LF 
PTA] 
45.0 ± 16.7 
dB HL 
[250Hz] 
79.1 ± 9.2 dB 
HL [750Hz] 
1 yr post-op 
68.5 ± 21.7 
dB HL 
[MEAN LF 
PTA] 
85.0 ±14.9 
dB HL 
[750Hz] 
94.4% of 
subjects 
maintained at 
least partial 
hearing 
preservation at 
initial activation 
(17 of 28) 
 
5% of subjects 
had total hearing 
loss (1 of 18) 
-- 
Carvalho, G. M. et al. 
(2013). Hearing 
Preservation after 
Cochlear Implantation: 
UNICAMP Outcomes. 
(Carvalho et al., 2013) 
 
 
 
 
Total hearing 
preservation: a 
postoperative 
unaided hearing 
loss of 0–10 dB 
Partial hearing 
preservation: 
postoperative 
unaided hearing 
loss of >10 dB 
but ≤80 dB 
hearing or better 
in at least one 
frequency 
between 250 and 
1000 Hz 
[LF PTA 250-
1kHz] 
Subject 1 
65 dBHL 
 
At initial activation and 
after >1 year post-op 
1 subject maintained total 
hearing preservation; 
3 subjects achieved partial 
hearing preservation; 
2 subjects experienced 
hearing preservation failure 
66.7% of 
subjects 
maintained some 
degree of 
functional 
hearing for EAS 
use at initial 
activation and >1 
year post-op (4 
of 6) 
33.3% of subjects 
experienced a 
profound or non-
functional hearing 
loss both at initial 
activation and >1 
year post-op (2 of 
6) 
4/6 subjects 
continued use 
of EAS at >1 
year post-op 
Subject 2 
71.6 dBHL 
 
Subject 3 
48.3 dBHL 
 
Subject 4 
75 dBHL 
 
Subject 5 
66.6 dBHL 
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Hearing 
preservation 
failure: unaided 
postoperative 
thresholds 
are >80 dB 
Subject 6 
58.3 dBHL 
Gantz, B. J., et al. (2016). 
Multicenter clinical trial 
of the Nucleus Hybrid S8 
cochlear implant: Final 
outcomes: S8 Hybrid 
Cochlear Implants. 
(Gantz et al., 2016) 
 
Functional 
hearing 
preservation: 
<85-90 dBHL 
PTA of 125 to 
1kHz [LFPTA]; 
Non-functional 
hearing 
preservation:  
>90 dB LFPTA; 
Total loss of 
hearing:  
>130dBHL 
 
48.9 dB HL 
[mean PTA 125-
1kHz] 
 
63.6 dB HL LFPTA at 1-
month post-op (mean decline 
of 14.8 dB HL); 
*second smaller change 
noted in first 3 months, 
hearing then stabilized during 
remainder of trial (number 
not reported) 
 
94% of the 
subjects 
maintained 
functional 
hearing from 125 
to 500 Hz at 
initial activation 
(85 of 87) 
 
19.6% of subjects 
had non-
functional LFPTA 
at the 12 month 
evaluation (16 
subjects)  
 
 
-- 
Härkönen, K., et al. 
(2017). Hybrid cochlear 
implantation: quality of 
life, quality of hearing, 
and working 
performance compared 
to patients with 
conventional unilateral or 
bilateral cochlear 
implantation. (Härkönen 
et al., 2017) 
 
 
 
Mean LF 
hearing 
threshold decline 
125-500Hz in the 
implanted ear;  
Total loss of 
residual low-
frequency 
hearing 
Mean LF PTA 
was 
approximately 
18dBHL 
*exact number 
not reported; 
thresholds 
obtained from 
fig. 2  
Mean decrease in hearing in 
implanted ear:  
at 125Hz: 11dBHL 
at 250Hz: 14dBHL 
at 500Hz: 19dBHL 
mean PTA 125-500Hz: 
15dBHL 
 
87.5% of 
subjects 
maintained 
preserved LF 
residual hearing 
at the end of 
follow-up (7 of 8 
subjects; or 9 of 
10 ears) 
12.5% subject 
experienced total 
loss of residual 
hearing (1 of 8) 
-- 
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Lenarz, T., et al. (2013). 
European multi-centre 
study of the Nucleus 
Hybrid L24 cochlear 
implant. (Lenarz et al., 
2013) 
 
 
 
Completely 
conserved: 
defined as less 
than or equal to 
10 dB LF 
threshold 
increase; 
Partially or 
completely 
conserved: 
defined as less 
than or equal to 
30 dB LF 
threshold 
increase; 
Maintained 
residual hearing: 
defined as 
<90dB LF HL 
 
46.7 dB HL 
[125-500Hz] 
1-mo post-op 
61% of 
subjects 
hearing was 
completely 
conserved 
89% of 
subjects 
hearing was 
partially or 
completely 
conserved 
1-yr post op 
43% of 
subject’s 
hearing was 
completely 
conserved (-
18% points) 
74% of 
subject’s 
hearing was 
partially or 
completely 
conserved (-
15% points) 
98% of subjects 
maintained 
residual hearing 
at 500Hz 1-
month post-op; 
88% of subjects 
maintained 
residual hearing 
at 500Hz 12 
months post-op 
No subjects 
reportedly 
experienced 
significant/ total 
loss of hearing 
At one year 
post-op, 
88% of cases 
used 
combined 
electric and 
residual 
acoustic 
hearing in the 
implant ear 
Roland, J. T., et al. 
(2016). United States 
multicenter clinical trial 
of the cochlear nucleus 
hybrid implant system: 
Nucleus Hybrid Implant 
System Clinical Trial. 
(Roland et al., 2016) 
 
 
 
Profound 
hearing loss: 
greater than 
90dBHL; 
Functional 
acoustic 
hearing: less 
than or equal to 
90dBHL 
0–25 dB HL: 
1/50 (2.0%); 
26 - 40 dB HL: 
13/50 (26.0%); 
 41–55 dB HL: 
26/50 (52.0%); 
56 - 70 dB HL: 
10/50 (20.0%) 
LF PTA 6 months post-
activation (of subjects who 
maintained functional 
hearing) 
41–55 dB HL: 15/48 
(31.25%); 
56 - 70 dB HL: 9/48 (18.8%); 
71-90 dB HL: 9/48 (18.8%); 
66% of subjects 
maintained 
residual 
functional 
acoustic hearing 
at 6 months post-
activation (33 of 
50) 
30% experienced 
profound or total 
hearing loss (15 
of 50) 
-- 
Roland, J. T., et al. 
(2018). Long-term 
outcomes of cochlear 
implantation in patients 
with high-frequency 
hearing loss: Long-Term 
Electric-Acoustic 
Hearing Outcomes. 
(Roland et al., 2018) 
Functional 
Residual 
hearing: defined 
as 5 frequency 
LF PTA [125-
1kHz] greater 
than or equal to 
90 dBHL 
26–40 dB HL: 9 
subjects 
41–55 dB HL: 
16 subjects 
56–70 dB HL: 7 
subjects 
Functional Hearing 6 months 
post-activation: 84.4% of 
subjects 
Pre- to post- 
operative LF 
PTA differences 
were statistically 
significant 
(p<0.0001); 
LF PTA changes 
6 months to 5 
years were NOT 
6% of subjects at 
5 years post-
activation (2 of 
32) 
At 12 month 
post-
activation: 27 
or 32 subjects 
(84%); 
At 3 years 
post-
activation 26 
of 32 (81%);  
Functional Hearing 12 
months post-activation: 
87.5% of subjects 
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Measurable 
hearing: defined 
as any 
measurable 
threshold within 
that frequency 
range 
Total Loss: 
defined as no 
measurable 
thresholds at the 
limits of the 
equipment 
Functional Hearing 3 years 
post-activation: 87.5% of 
subjects 
statistically 
significant 
(p>0.05) 
At 5 years 
post-
activation 23 
of 32 (72%) 
Functional Hearing 5 years 
post-activation: 87.5% of 
subjects 
Santa Maria, P. L., et al. 
(2013). Hearing 
Preservation Surgery for 
Cochlear Implantation—
Hearing and Quality of 
Life After 2 Years. (Santa 
Maria et al., 2013) 
 
 
 
Complete 
hearing 
preservation (0-
25%);  
Partial hearing 
preservation (25-
60%);  
Minimal hearing 
preservation 
(>60%);  
Complete loss of 
hearing (no 
measurable 
hearing) 
<65dB HL at 
frequencies 
<500Hz 
< 3 months post-op 
Complete hearing 
preservation: 42.9% 
Partial: 50% 
Minimal: 7.1% 
 
100% hearing 
preservation at 
<3 months post-
op; 87.5% 
experiences 
some degree of 
hearing 
preservation 
at >24 months 
post-op 
12.5% of subjects 
experienced 
complete loss of 
hearing at >24 
months post-op 
6 of 11 
patients were 
still utilizing 
EAS 18 
months post-
activation 
6 to 12 months post-op 
Complete hearing 
preservation: 22.2% 
Partial: 66.7% 
Minimal: 11.1% 
 
12 to 24 months post-op 
Complete hearing 
preservation: 33.3% 
Partial: 22.2% 
Minimal: 44.4% 
 
>24 months post-op 
Complete hearing 
preservation: 25% 
Partial: 12.5% 
Minimal: 37.5% 
Complete loss: 12.5% 
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Skarzynski, H., et al. 
(2014). Cochlear 
Implantation With the 
Nucleus Slim Straight 
Electrode in Subjects 
With Residual Low-
Frequency Hearing. 
(Skarzynski et al., 2014) 
 
 
Average 
decrease in 
hearing at 125, 
250, and 500Hz. 
(1) preserved 
within 10dB of 
pre-op values  
(2) preserved 
within 30dB of 
pre-op values 
Group 1 
250Hz: 27.7 
(10.3 SD) 
500Hz: 32.3 
(13.1 SD)  
1000Hz: 68.2 
(22.1 SD) 
1 mo post-op 
- Average LF 
PTA decline 
of 10dB HL 
- 43% of 
subjects had 
preserved 
hearing 
within 10dB 
HL  
- 86% of 
subjects had 
preserved 
hearing 
within 30dB 
HL 
 
1 yr post-op 
-Average LF 
PTA decline 
of 15dB HL 
- 38% of 
subjects had 
preserved 
hearing 
within 10dB 
HL  
- 79% of 
subjects had 
preserved 
hearing 
within 30dB 
HL 
 
91% of subjects 
maintained some 
degree of 
residual hearing 
1 month post-op 
9% subjects 
experienced total 
loss of functional 
hearing at 1 year 
post-op (3 
subjects) 
-- 
Group 2 
250Hz: 45.8 
(14.8 SD) 
500Hz: 63.8 (8.2 
SD) 
1000Hz: 91.9 
(14.9 SD) 
Group 3 
250Hz: 66.8 
(18.5 SD) 
500Hz: 90.5 
(12.1 SD) 
1000Hz: 102.3 
(8.8 SD) 
Usami, S.-I., et al. (2014). 
Hearing preservation and 
clinical outcome of 32 
consecutive electric 
acoustic stimulation 
(EAS) surgeries. (Usami 
et al., 2014) 
Average change 
in threshold 125-
1000Hz from 
pre-op to 12-
month post-op 
27.5dB HL at 
125Hz; 
35.5dB HL at 
250Hz; 
52.3dB HL at 
500Hz; 
85.2dB HL at 
1000Hz 
 
 
Mean:  
50.13dB HL 
1 mo post-op 
40.3 dB HL 
at 125Hz; 
53.8 dB HL 
at 250Hz; 
76.7 dB HL 
at 500Hz; 
93.8 dB HL 
at 1000Hz 
 
Mean: 
66.15dB HL 
 
1 yr post-op 
41.9 dB HL 
at 125Hz; 
55.2 dB HL 
at 250Hz; 
79.8 dB HL 
at 500Hz; 
96.7 dB HL 
at 1000Hz 
 
Mean:  
68.4dB HL 
93.3% of 
subjects 
maintained 
sufficient 
residual LF HL 
for EAS 
7% subjects 
experienced loss 
of hearing that 
was not sufficient 
to utilize acoustic 
stimulation (2 of 
30) 
-- 
HL: Hearing Loss; LF: Low Frequency; LF PTA: Low Frequency Pure Tone Average; PTA: Pure Tone Average; SD: Standard Deviation 
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Discussion 
The primary purpose of this investigation was to perform a systematic review of the 
current literature regarding users of hybrid cochlear implantation and their speech recognition 
outcomes, as well as subjective performance. Degrees of hearing preservation following cochlear 
implant surgery was also extracted and analyzed.  
 In total, ten studies were included in this review which yielded a total overall sample size 
of 326 subjects with an average sample size of 32.6. Speech recognition outcomes were assessed 
using several materials and measures. The most common speech measure in quiet was CNC 
words, used in five of the ten studies. Adunka et al., 2013, Gantz et al., 2016, Roland et al., 2016, 
Roland et al., 2018, and Santa Maria et al., 2013 all concluded significant improvements in CNC 
speech scores from pre-operatively to post-operatively. Other speech measures in quiet 
performed in the remaining studies, again, yielded significant post-operative score 
improvements. This is suggestive of significant benefit from cochlear implantation in this 
population. The two remaining studies, Härkönen et al., 2017 and Carvalho et al., 2013, reported 
overall improvments in scores, but nothing was reported regarding the significance of these 
differences. As the vast majority of subjects in these studies experienced a positive improvement, 
one can assume that the benefit was favorable.  
Other than CNC words, 15 other speech measures were used to assess speech outcomes. 
The majority of the studies chose to use some kind of speech in noise measure to assess benefit 
in more difficult listening situations. Speech in noise tends to be a frequently reported complaint 
for both cochlear implant and hearing aid users. As previously noted in the introduction of this 
review, recent research has proposed that the use of acoustic cues in low frequency hearing may 
improve speech understanding in noise. The proposed reasoning is that users can take advantage 
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of the acoustic cues that are not preserved in traditional cochlear implant speech processing 
strategies. Eight of the ten studies included a speech in noise measure, while six of those eight 
studies reported significant improvements in words and sentences in noise, pre-operatively to 
post-operatively (Adunka et al., 2013, Gantz et al., 2016, Lenarz et al., 2013, Roland et al., 2016, 
Skarzynski et al., 2014, Usami et al., 2014). Härkönen et al., 2017, as previously stated, did not 
report significance findings but noted a high level of achievement in challenging speech in noise 
conditions. Whereas Santa Maria et al., 2013 stated that subjects had an overall better signal to 
noise ratio in their speech in noise measure, but this difference was not significant. 
 To better assess the use of acoustic hearing in cochlear implantation, nine of the studies 
included a comparison of EAS verses no EAS use. In the process, the studies attempted to 
demonstrate the benefit the acoustic component provided. How they chose to report said benefit 
varied greatly and, in turn, mixed findings were noted in terms of signficant benefit. Four studies 
reported that the use of the acoustic component yielded a significant improvement in speech 
scores, while three studies reported that there was substantial improvement but no significance 
was reported. Lastly, two studies noted that there were no notable differences between those 
subjects utilizing EAS and those who used traditional cochlear implantation.  
 Based on the previously noted conclusions, research question one, “Does electric acoustic 
stimulation (EAS) through the use of hybrid cochlear implants improve speech recognition 
outcomes in adults? If so, to what degree?”, may be addressed. Subjects in all studies 
experienced positive improvements from hybrid cochlear implantation. The degree to which they 
benefitted varied, but was overall significant pre- to post-operatively. Based on these findings it 
may be concluded that these individuals, who would not have been traditional cochlear implant 
candidates, are seeing significant positive changes post-implantation. As a secondary finding of 
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interest, we may also conclude that the benefit of the acoustic component is difficult to quantify, 
but the majority of studies experienced some degree of benefit from the use of EAS. These are 
favorable conclusions for the proposed recommendation of expanding cochlear implant 
candidacy criteria. 
 A secondary outcome measure extracted in this review was subjective performance using 
a number of materials and measures. The SSQ was by far the most common subjective measure 
used amongst the seven studies which included such analysis. Overall, subjects experienced a 
significant positive subjective benefit from cochlear implantation in a number of subscales. In 
reference to research question two, “What were the subjective improvements experienced by the 
EAS subjects on qualitative outcome measures?”, the impression of the extracted information 
suggests that patients subjectively report a high level of satisfaction and benefit after going 
through with implantation. In a patient centered field, subjective report from amplification users 
is essential in promoting an initiative of expanded candidacy.  
 Hearing preservation was also a topic of particular interest in this study. One of the 
emerging subjects of research in this field is the improvement of surgical techniques in order to 
better preserve residual low frequency hearing during cochlear implant surgery. These “soft” 
surgical techniques, as they are called, have improved substantially in recent years with the 
growing popularity of hybrid cochlear implants. While hearing preservation outcomes have 
improved, there is still much room for growth before surgeons are able to achieve total 
preservation in these candidates. For this reason, degree of hearing maintained after surgery was 
reported in all studies in this review and was summarized in Table 5. Of particular interest in 
these studies is the ability to preserve enough “functional” hearing. “Functional” hearing refers 
to low frequency threshold levels that can be amplified acoustically through the acoustic 
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component of a hybrid implant system. Should threshold levels drop too low due to damage 
caused from implantation, they are no longer of use or “aidable” for the purpose of EAS. For this 
reason, hearing preservation can be deemed “non-functional” or unable to be aided acoustically. 
In addressing research question three, “What proportion of hybrid cochlear implantees 
maintained low frequency residual hearing following cochlear implant surgery? If so, to what 
degree was low frequency hearing preserved?”, hearing preservation was achieved in all studies 
to varying degrees. The ability to preserve functional hearing was overwhelmingly successful, 
with between 66-100% of subjects maintaining at least partial residual hearing after 
implantation. Studies also reported that between 0-33.3% of subjects experienced a total or “non-
functional” loss of hearing. True degrees of hearing preservation were heavily dependent on the 
pre-operative thresholds themselves. As a limitation to this conclusion, what each study qualified 
as “preserved” varied greatly. Future research may aim to keep these degrees of preservation 
more consistent and determine if these percentages can improve with improved surgical 
techniques. Also of note was the four studies which reported on long-term use of EAS and its 
discontinued use. Continued use had great variability with 54.5-88% of subjects still utilizing 
EAS at more than one year after implantation. A common reason for discontinued use is the 
further decline in hearing thresholds in the months to years following implantation, making these 
subjects ineligible for acoustic stimulation. A topic of future research may look into the long-
term use of EAS and the reasoning behind its dicontinued use. As EAS is a more recent 
development in the realm of cochlear implants, it may now be of interest to investigate these 
long term implications.  
Hybrid cochlear implantation has offered a new amplification solution for a previously 
excluded and underserved population. These individuals were historically treated with traditional 
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hearing aids but received limited benefit from the devices. Previous restrictions prevented them 
from obtaining cochlear implants as they did not meet the typical candidacy criteria. The 
findings concluded in this systematic review may serve as evidentiary support for the expansion 
of cochlear implantation criteria as specified by the FDA. The expansion of cochlear implant 
criteria to include hybrid cochlear implant candidates should reflect the growing population of 
potential users.  
Table 6 outlines the candidacy criteria of an ideal EAS candidate that may benefit from 
the advantages noted. As previously discussed, the FDA leaves much of the recommendation for 
cochlear implantation up to the clinician. Through “off-labeling” clinicians can make a clinic 
judgement of the potential benefit for a patient. However, insurance payers, particularly 
Medicare, put in place candidacy restrictions that are required for approval in order to receive 
coverage. The ideal candidate will meet said criteria, as specified by the FDA, for hearing 
thresholds, speech scores, hearing aid benefit, and contraindications to surgery. The following 
table displays the suggested criteria: 
 Table 6: EAS Candidacy  
 (FDA, 2016); (FDA, 2018); (Med-El, 2020) 
Ideal EAS candidate 
• Low frequency thresholds obtained within normal limits to a moderate sensorineural 
hearing loss (approximate; exact cut-off threshold is manufacturer specific) 
• Mid to high frequency thresholds obtained at a severe to profound sensorineural 
hearing loss 
• Monosyllabic speech scores of £60% in the best aided condition and £50% in the ear to 
be implanted (for third party insurers- as per standard FDA candidacy criteria) 
• Limited benefit from appropriately fit traditional amplification after an adequate trial 
period 
• No contraindications to surgery 
• No contraindications to use of an external amplification component (ie. microtia, 
atresia, middle ear drainage) 
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Of importance are the advantages and disadvantages to hybrid cochlear implantation, 
particularly in comparison to traditional amplification. Such advantages include improved speech 
understanding, especially in noise, as demonstrated by the included studies. Potential hybrid 
candidates have poor speech recognition scores such that traditional amplification cannot solve 
their issues with clarity, and this difficulty is often exacerbated in noise. A secondary advantage 
this review has presented is the improvement in subjective outcomes as reported by subjects. All 
studies indicated subjects experienced positive improvements pre- to post- implantation 
indicating a high level of satisfaction with their decision. There are potential disadvantages 
associated with hybrid implantation which have also been uncovered in this review. The first of 
which is the potential loss of residual hearing from implantation. The majority of studies have 
indicated that while hearing preservation was overall successful, some degree of hearing was lost 
in all patients to varying degrees. The trauma of surgery puts at risk the delicate structures of the 
inner ear resulting in a decline in hearing. Another potential disadvantage comes from the risks 
associated with any surgery. While cochlear implantation surgery is generally well-tolerated, 
there are standard risks associated with any surgical procedure that should be considered. 
Potential surgical complications include injury to the facial nerve, post-operative tinnitus or 
vertigo, infection at the skin wound, or potential electrode migration or misplacement (Jeppesen 
& Faber, 2013). For this reason, patients may choose the less invasive option. Another 
disadvantage to discuss with patients is the acclimatization period and the difference in sound 
quality a patient will experience post-implantation. Pre-operative counseling is essential to 
prepare the patient for what to expect immediately after activation. Transparency of the benefits 
and limitations of a hybrid cochlear implant can aid in this decision making. This review has 
summarized the literature’s conclusions of the potential advantages and disadvantages.  
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There are limitations to this review related to the inconsistency in reporting across 
studies. These inconsistencies are present in different follow-up periods, different outcome 
measures, and different testing conditions. For these reasons, we are limited in the conclusions 
we can draw from the given data and may only report on overall trends. A second limitation is 
that the electrode arrays used in the included studies are not reflective of the vast advancements 
currently being used in today’s devices. As we are at the forefront of hybrid cochlear implant 
usage, the technology changes rapidly and can become obsolete. Although exclusion criteria 
were put in place to limit included studies to those published since 2013, the need for more 
current research is evident as the devices used today do not reflect the devices used at the time of 
data collection. Future recommendations and initiatives may aim at increasing awareness for 
cochlear implant evaluation referrals from non-cochlear implant audiologists. The most effective 
way to identify this population is to have audiologists become more aware that hybrid cochlear 
implants are a potential option for these patients. Future directions of research may look at how 
and when these referrals are occurring and what can be done to increase such awareness. Future 
clinic recommendations should reflect the mission to refer these patients for evaluation. Without 
these recommendations, we will continue to see this population perform poorly with traditional 
hearing aids. Other topics of potential research include the long-term usage of hybrid cochlear 
implants, as there are varying reports of use and minimal follow-up regarding reasoning of 
discontinued use. Having such data may lead to a better understanding of the benefits and 
limitations of said devices. Lastly, further research should be dedicated to quantifying the benefit 
of acoustic stimulation in hybrid cochlear implants. This may allow for further conclusions of the 
potential advantages of acoustic hearing in regards to current speech coding strategies. The 
conclusions and data extracted in this review should serve to support this future research. 
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Conclusions 
In this systematic review, the existing literature on the speech outcomes, subjective 
outcomes, and hearing preservation of hybrid cochlear implant users was extracted and reviewed. 
The findings indicated an overall positive improvement in speech perception and subjective 
performance from pre-operatively to post-operatively. Functional hearing preservation was well 
maintained in all studies, to varying degrees, to enable to use of electric acoustic stimulation. The 
concluded evidence in this review many serve as justification and evidentiary support of the 
expansion of cochlear implant criteria to include this underserved population. Future research 
may focus on the discontinued use of EAS, audiologist referral of this population, and the 
quantifying of benefit of the acoustic component in the hybrid cochlear implant system.    
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